Infection with a fungus of the genus CANDIDA. It is usually a superficial infection of the moist areas of the body and is generally caused by CANDIDA ALBICANS. (Dorland, 27th ed)
Infection of the mucous membranes of the mouth by a fungus of the genus CANDIDA. (Dorland, 27th ed)
Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.
An important nosocomial fungal infection with species of the genus CANDIDA, most frequently CANDIDA ALBICANS. Invasive candidiasis occurs when candidiasis goes beyond a superficial infection and manifests as CANDIDEMIA, deep tissue infection, or disseminated disease with deep organ involvement.
Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (Dorland, 27th ed)
A unicellular budding fungus which is the principal pathogenic species causing CANDIDIASIS (moniliasis).
A clinical syndrome characterized by development, usually in infancy or childhood, of a chronic, often widespread candidiasis of skin, nails, and mucous membranes. It may be secondary to one of the immunodeficiency syndromes, inherited as an autosomal recessive trait, or associated with defects in cell-mediated immunity, endocrine disorders, dental stomatitis, or malignancy.
A genus of yeast-like mitosporic Saccharomycetales fungi characterized by producing yeast cells, mycelia, pseudomycelia, and blastophores. It is commonly part of the normal flora of the skin, mouth, intestinal tract, and vagina, but can cause a variety of infections, including CANDIDIASIS; ONYCHOMYCOSIS; vulvovaginal candidiasis (CANDIDIASIS, VULVOVAGINAL), and thrush (see CANDIDIASIS, ORAL). (From Dorland, 28th ed)
Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues.
Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
Immunoglobulins produced in a response to FUNGAL ANTIGENS.
Pathological processes involving the PHARYNX.
Pathological processes in the ESOPHAGUS.
Cyclic hexapeptides of proline-ornithine-threonine-proline-threonine-serine. The cyclization with a single non-peptide bond can lead them to be incorrectly called DEPSIPEPTIDES, but the echinocandins lack ester links. Antifungal activity is via inhibition of 1,3-beta-glucan synthase production of BETA-GLUCANS.
Substances of fungal origin that have antigenic activity.
The middle portion of the pharynx that lies posterior to the mouth, inferior to the SOFT PALATE, and superior to the base of the tongue and EPIGLOTTIS. It has a digestive function as food passes from the mouth into the oropharynx before entering ESOPHAGUS.
Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
Polyhydric alcohols having no more than one hydroxy group attached to each carbon atom. They are formed by the reduction of the carbonyl group of a sugar to a hydroxyl group.(From Dorland, 28th ed)
Suspensions of attenuated or killed fungi administered for the prevention or treatment of infectious fungal disease.
An imidazole derivative with a broad spectrum of antimycotic activity. It inhibits biosynthesis of the sterol ergostol, an important component of fungal CELL MEMBRANES. Its action leads to increased membrane permeability and apparent disruption of enzyme systems bound to the membrane.
The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.
Compounds consisting of a short peptide chain conjugated with an acyl chain.
A form of invasive candidiasis where species of CANDIDA are present in the blood.
A species of MITOSPORIC FUNGI commonly found on the body surface. It causes opportunistic infections especially in immunocompromised patients.
The ability of fungi to resist or to become tolerant to chemotherapeutic agents, antifungal agents, or antibiotics. This resistance may be acquired through gene mutation.
The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)
Opportunistic infections found in patients who test positive for human immunodeficiency virus (HIV). The most common include PNEUMOCYSTIS PNEUMONIA, Kaposi's sarcoma, cryptosporidiosis, herpes simplex, toxoplasmosis, cryptococcosis, and infections with Mycobacterium avium complex, Microsporidium, and Cytomegalovirus.
Polysaccharides consisting of mannose units.
A species of MITOSPORIC FUNGI that is a major cause of SEPTICEMIA and disseminated CANDIDIASIS, especially in patients with LYMPHOMA; LEUKEMIA; and DIABETES MELLITUS. It is also found as part of the normal human mucocutaneous flora.
Inflammation of the vagina characterized by pain and a purulent discharge.
An imidazole antifungal agent that is used topically and by intravenous infusion.
Peptides whose amino and carboxy ends are linked together with a peptide bond forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS. Some of them are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL).
Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations.
Glucose polymers consisting of a backbone of beta(1->3)-linked beta-D-glucopyranosyl units with beta(1->6) linked side chains of various lengths. They are a major component of the CELL WALL of organisms and of soluble DIETARY FIBER.
A type of irritant dermatitis localized to the area in contact with a diaper and occurring most often as a reaction to prolonged contact with urine, feces, or retained soap or detergent.
Autoimmune diseases affecting multiple endocrine organs. Type I is characterized by childhood onset and chronic mucocutaneous candidiasis (CANDIDIASIS, CHRONIC MUCOCUTANEOUS), while type II exhibits any combination of adrenal insufficiency (ADDISON'S DISEASE), lymphocytic thyroiditis (THYROIDITIS, AUTOIMMUNE;), HYPOPARATHYROIDISM; and gonadal failure. In both types organ-specific ANTIBODIES against a variety of ENDOCRINE GLANDS have been detected. The type II syndrome differs from type I in that it is associated with HLA-A1 and B8 haplotypes, onset is usually in adulthood, and candidiasis is not present.
Pathological processes of the VAGINA.
A muscular organ in the mouth that is covered with pink tissue called mucosa, tiny bumps called papillae, and thousands of taste buds. The tongue is anchored to the mouth and is vital for chewing, swallowing, and for speech.
Infections with fungi of the genus ASPERGILLUS.
Inflammation of the VULVA and the VAGINA, characterized by discharge, burning, and PRURITUS.
Microscopic threadlike filaments in FUNGI that are filled with a layer of protoplasm. Collectively, the hyphae make up the MYCELIUM.
Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
Polymicrobial, nonspecific vaginitis associated with positive cultures of Gardnerella vaginalis and other anaerobic organisms and a decrease in lactobacilli. It remains unclear whether the initial pathogenic event is caused by the growth of anaerobes or a primary decrease in lactobacilli.
A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
Proteins found in any species of fungus.
Antibodies which elicit IMMUNOPRECIPITATION when combined with antigen.
MYCOSES of the brain, spinal cord, and meninges which may result in ENCEPHALITIS; MENINGITIS, FUNGAL; MYELITIS; BRAIN ABSCESS; and EPIDURAL ABSCESS. Certain types of fungi may produce disease in immunologically normal hosts, while others are classified as opportunistic pathogens, causing illness primarily in immunocompromised individuals (e.g., ACQUIRED IMMUNODEFICIENCY SYNDROME).
Macrolide antifungal antibiotic complex produced by Streptomyces noursei, S. aureus, and other Streptomyces species. The biologically active components of the complex are nystatin A1, A2, and A3.
Five membered rings containing a NITROGEN atom.
A decrease in the number of NEUTROPHILS found in the blood.
The study of the structure, growth, function, genetics, and reproduction of fungi, and MYCOSES.
The oval-shaped oral cavity located at the apex of the digestive tract and consisting of two parts: the vestibule and the oral cavity proper.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
A subclass of peptide hydrolases that depend on an ASPARTIC ACID residue for their activity.
An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.
A common gynecologic disorder characterized by an abnormal, nonbloody discharge from the genital tract.
Epithelial hyperplasia of the oral mucosa associated with Epstein-Barr virus (HERPESVIRUS 4, HUMAN) and found almost exclusively in persons with HIV infection. The lesion consists of a white patch that is often corrugated or hairy.
Inflammation of the vagina, marked by a purulent discharge. This disease is caused by the protozoan TRICHOMONAS VAGINALIS.
Broad spectrum antifungal agent used for long periods at high doses, especially in immunosuppressed patients.
A family of fused-ring hydrocarbons isolated from coal tar that act as intermediates in various chemical reactions and are used in the production of coumarone-indene resins.
Complete or severe loss of the subjective sense of taste, frequently accompanied by OLFACTION DISORDERS.
The degree of pathogenicity within a group or species of microorganisms or viruses as indicated by case fatality rates and/or the ability of the organism to invade the tissues of the host. The pathogenic capacity of an organism is determined by its VIRULENCE FACTORS.
A group of small, histidine-rich, cationic peptides in human SALIVA which are antibacterial and antifungal.
An EPITHELIUM with MUCUS-secreting cells, such as GOBLET CELLS. It forms the lining of many body cavities, such as the DIGESTIVE TRACT, the RESPIRATORY TRACT, and the reproductive tract. Mucosa, rich in blood and lymph vessels, comprises an inner epithelium, a middle layer (lamina propria) of loose CONNECTIVE TISSUE, and an outer layer (muscularis mucosae) of SMOOTH MUSCLE CELLS that separates the mucosa from submucosa.
Deoxyribonucleic acid that makes up the genetic material of fungi.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
A fluorinated cytosine analog that is used as an antifungal agent.
A constitution or condition of the body which makes the tissues react in special ways to certain extrinsic stimuli and thus tends to make the individual more than usually susceptible to certain diseases.
OPPORTUNISTIC INFECTIONS with the soil fungus FUSARIUM. Typically the infection is limited to the nail plate (ONYCHOMYCOSIS). The infection can however become systemic especially in an IMMUNOCOMPROMISED HOST (e.g., NEUTROPENIA) and results in cutaneous and subcutaneous lesions, fever, KERATITIS, and pulmonary infections.
Infection with a fungus of the species CRYPTOCOCCUS NEOFORMANS.
Inflammation of the mouth due to denture irritation.
An appliance used as an artificial or prosthetic replacement for missing teeth and adjacent tissues. It does not include CROWNS; DENTAL ABUTMENTS; nor TOOTH, ARTIFICIAL.
Mentha is a genus of the mint family (LAMIACEAE). It is known for species having characteristic flavor and aroma.
A sub-subclass of endopeptidases that depend on an ASPARTIC ACID residue for their activity.
A decrease in the number of GRANULOCYTES; (BASOPHILS; EOSINOPHILS; and NEUTROPHILS).
Pulmonary diseases caused by fungal infections, usually through hematogenous spread.
Pathological processes involving the STOMACH.
Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).
Animals not contaminated by or associated with any foreign organisms.
Hospital units providing continuing surveillance and care to acutely ill newborn infants.
The giving of drugs, chemicals, or other substances by mouth.
The return of a sign, symptom, or disease after a remission.
Essential oil extracted from Melaleuca alternifolia (tea tree). It is used as a topical antimicrobial due to the presence of terpineol.
Inorganic and organic derivatives of boric acid either B(OH)3 or, preferably H3BO3.
The number of CD4-POSITIVE T-LYMPHOCYTES per unit volume of BLOOD. Determination requires the use of a fluorescence-activated flow cytometer.
An infant whose weight at birth is less than 1000 grams (2.2 lbs), regardless of GESTATIONAL AGE.
INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.
Passive agglutination tests in which antigen is adsorbed onto latex particles which then clump in the presence of antibody specific for the adsorbed antigen. (From Stedman, 26th ed)
An infant during the first month after birth.
Substances, usually of biological origin, that cause cells or other organic particles to aggregate and stick to each other. They include those ANTIBODIES which cause aggregation or agglutination of particulate or insoluble ANTIGENS.
Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM.
The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.
Procedures for identifying types and strains of fungi.
The washing of the VAGINA cavity or surface with a solution. Agents or drugs can be added to the irrigation solution.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Meningitis caused by fungal agents which may occur as OPPORTUNISTIC INFECTIONS or arise in immunocompetent hosts.
A naturally occurring glucocorticoid. It has been used in replacement therapy for adrenal insufficiency and as an anti-inflammatory agent. Cortisone itself is inactive. It is converted in the liver to the active metabolite HYDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p726)
A plant genus of the family MYRTACEAE. M. alternifolia foliage is a source of TEA TREE OIL. The common name of tea tree also refers to LEPTOSPERMUM or KUNZEA. M. vindifolia is a source of niaouli oil. M. cajuputi and M. leucadendra are sources of cajuput oil.
The clear, viscous fluid secreted by the SALIVARY GLANDS and mucous glands of the mouth. It contains MUCINS, water, organic salts, and ptylin.
A plant genus of the family FABACEAE. Many species of this genus, including the medicinal C. senna and C. angustifolia, have been reclassified into the Senna genus (SENNA PLANT) and some to CHAMAECRISTA.
A plant species of the genus CINNAMOMUM that contains CINNAMATES and has been used in traditional Chinese medicine (DRUGS, CHINESE HERBAL).
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
The muscular membranous segment between the PHARYNX and the STOMACH in the UPPER GASTROINTESTINAL TRACT.
A plant genus of the family GERANIACEAE. Geranium is also used as a common name for PELARGONIUM.
Immunoelectrophoresis in which immunoprecipitation occurs when antigen at the cathode is caused to migrate in an electric field through a suitable medium of diffusion against a stream of antibody migrating from the anode as a result of endosmotic flow.
The ability of lymphoid cells to mount a humoral or cellular immune response when challenged by antigen.

Biotyping and virulence properties of skin isolates of Candida parapsilosis. (1/55)

The biotype and virulence of skin isolates of Candida parapsilosis were compared with blood isolates of the same fungus. Morphotype, resistotype, and electrophoretic karyotype determinations did not reveal any special cluster with a unique or dominant pathogenic feature among all of the isolates, regardless of their source. However, all cutaneous isolates had uniformly elevated secretory aspartyl-protease (Sap) activity, more than four times higher than the enzyme activity of the blood isolates. They were also highly vaginopathic in a rat vaginitis model, being significantly more virulent than blood isolates in this infection model. In contrast, skin isolates were nonpathogenic in systemic infection of cyclophosphamide-immunodepressed mice, while some blood isolates were, in this model, highly pathogenic (median survival time, 2 days, with internal organ invasion at autopsy). Finally, skin isolates did not differ, as a whole, from blood isolates in their adherence to plastic. This property was associated with a morphotype, as defined by a colony with continuous fringe, which was present among both skin and blood isolates. While confirming the genetic heterogenicity of C. parapsilosis, our data strongly suggest that the potential of this fungus to cause mucosal disease is associated with Sap production and is substantially distinct from that of systemic invasion.  (+info)

Misexpression of the opaque-phase-specific gene PEP1 (SAP1) in the white phase of Candida albicans confers increased virulence in a mouse model of cutaneous infection. (2/55)

Candida albicans WO-1 switches reversibly and at high frequency between a white and an opaque colony-forming phenotype that includes dramatic changes in cell morphology and physiology. A misexpression strategy has been used to investigate the role of the opaque-phase-specific gene PEP1 (SAP1), which encodes a secreted aspartyl proteinase, in the expression of the unique opaque-phase phenotype and phase-specific virulence in two animal models. The PEP1 (SAP1) open reading frame was inserted downstream of the promoter of the white-phase-specific gene WH11 in the transforming vector pCPW7, and the resulting transformants were demonstrated to misexpress PEP1 (SAP1) in the white phase. Misexpression did not confer any of the unique morphological characteristics of the opaque phase to cells in the white phase and had no effect on the switching process. However, misexpression conferred upon white-phase cells the increased capacity of opaque-phase cells to grow in medium in which protein was the sole nitrogen source. Misexpression of PEP1 (SAP1) had no effect on the virulence of white-phase cells in a systemic mouse model, in which white-phase cells were already more virulent than opaque-phase cells. Misexpression did, however, confer upon white-phase cells the dramatic increase in colonization of skin in a cutaneous mouse model that was exhibited by opaque-phase cells. Misexpression of PEP1 (SAP1) conferred upon white-phase cells two dissociable opaque-phase characteristics: increased adhesion and the capacity to cavitate skin. The addition of pepstatin A to the cutaneous model inhibited the latter, but not the former, suggesting that the latter is effected by released enzyme, while the former is effected by cell-associated enzyme.  (+info)

In vitro antifungal activity of KP-103, a novel triazole derivative, and its therapeutic efficacy against experimental plantar tinea pedis and cutaneous candidiasis in guinea pigs. (3/55)

The in vitro activity of KP-103, a novel triazole derivative, against pathogenic fungi that cause dermatomycoses and its therapeutic efficacy against plantar tinea pedis and cutaneous candidiasis in guinea pigs were investigated. MICs were determined by a broth microdilution method with morpholinepropanesulfonic acid-buffered RPMI 1640 medium for Candida species and with Sabouraud dextrose broth for dermatophytes and by an agar dilution method with medium C for Malassezia furfur. KP-103 was the most active of all the drugs tested against Candida albicans (geometric mean [GM] MIC, 0.002 microg/ml), other Candida species including Candida parapsilosis and Candida glabrata (GM MICs, 0.0039 to 0.0442 microg/ml), and M. furfur (GM MIC, 0.025 microg/ml). KP-103 (1% solution) was highly effective as a treatment for guinea pigs with cutaneous candidiasis and achieved mycological eradication in 8 of the 10 infected animals, whereas none of the imidazoles tested (1% solutions) was effective in even reducing the levels of the infecting fungi. KP-103 was as active as clotrimazole and neticonazole but was less active than lanoconazole and butenafine against Trichophyton rubrum (MIC at which 80% of isolates are inhibited [MIC(80)], 0.125 microg/ml) and Trichophyton mentagrophytes (MIC(80), 0.25 microg/ml). However, KP-103 (1% solution) exerted therapeutic efficacy superior to that of neticonazole and comparable to those of lanoconazole and butenafine, yielding negative cultures for all samples from guinea pigs with plantar tinea pedis tested. This suggests that KP-103 has better pharmacokinetic properties in skin tissue than the reference drugs. Because the in vitro activity of KP-103, unlike those of the reference drugs, against T. mentagrophytes was not affected by hair as a keratinic substance, its excellent therapeutic efficacy seems to be attributable to good retention of its antifungal activity in skin tissue, in addition to its potency.  (+info)

Different isoforms of secreted aspartyl proteinases (Sap) are expressed by Candida albicans during oral and cutaneous candidosis in vivo. (4/55)

Distinct isoforms of secreted aspartyl proteinases (Sap) of Candida albicans are important virulence factors for different types of candidosis. Predominant expression of Sap1-3 has been shown to be crucial for superficial infections in experimental mucosal and cutaneous candidosis, whereas Sap4-6 might be important for systemic disease. This in-vivo study investigated Sap expression in two samples from patients with oral candidosis and from cutaneous infection. Two different polyclonal antibodies directed against Sap1-3 and Sap4-6 were used for ultrastructural characterisation of protein localisation and expression. Post-embedding immuno-electron microscopy revealed Sap1-3 and Sap4-6 immunoreactivity in all samples. All C. albicans cells expressed predominantly the proteinases Sap1-3 which were evenly distributed within the cell wall and cytoplasmic membrane. In contrast, Sap4-6 labelling was only evident in a few fungal cells. In particular it was localised at the tips of hyphal cells during invasion. These data suggest a different pathogenetic role for Sap1-3 and Sap4-6 during host-fungal interaction.  (+info)

Quantification of Candida albicans actin mRNA by the LightCycler system as a means of assessing viability in a model of cutaneous candidiasis. (5/55)

The LightCycler system (two-step reverse transcription-PCR-fluorescent hybridization [LC RT-PCR-FH]) was used to quantify Candida albicans actin mRNA as a means of assessing its viability in a reconstituted skin model of cutaneous candidiasis following the application of an antimycotic. A 192-bp ACT exon fragment was ligated into the pCR2.1 plasmid vector, and dilutions of the cloned insert (pACT; 4.092 kb) were used as the standard reference template. The LC RT-PCR-FH system could detect 1 fg of pACT, equivalent to 2.2 copies of the plasmid. The ACT exon-based PCR primers and FH probes were C. albicans specific, and electrophoretic analysis of the LC RT-PCR-FH assay product showed a 174-bp band in agarose gel. The number of copies of C. albicans ACT mRNA per milligram of tissue decreased with increasing amounts of amorolfine applied to a C. albicans-infected skin model, showing a reduction in viability. Detection and quantification of ACT mRNA in tissue by the LC RT-PCR-FH assay corresponded with cultural isolation of C. albicans from samples. The ACT mRNA-targeted LC RT-PCR-FH assay represents a sensitive, specific, rapid, and quantitative means of assessing the viability of C. albicans in infected tissue. This method may also be useful in evaluating the therapeutic efficacies of antifungal drugs in the treatment of various forms of candidiasis and other fungal diseases.  (+info)

Revisiting the source of candidemia: skin or gut? (6/55)

The source of candidemia has been the subject of considerable debate, with some suggesting a origin in the gastrointestinal tract and others suggesting a skin origin. To evaluate the potential sources of candidemia, we performed a computerized search of the MEDLINE database for studies published from January 1966 through September 2000 and we identified relevant abstracts presented at national meetings. We reviewed the literature with special emphasis on studies that used appropriate definitions, evaluated both gut and skin as sources, and conducted molecular-relatedness studies. Among 203 candidemia studies published, we identified 21 that evaluated a specific source for candidemia and only 5 that performed molecular typing. Those studies and additional experimental, epidemiologic, and molecular-relatedness studies strongly suggested that the gut is an important source of candidemia, and studies that supported the skin as a source for this infection were surprisingly incomplete.  (+info)

Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis. (7/55)

Skin equivalents based on reconstituted human epidermis have been used recently to establish models for allergic/irritant contact dermatitis and cutaneous candidosis. In the present study the cytokine expression pattern and the morphological alterations in experimental cutaneous candidosis were investigated by RT-PCR and histological analysis. In experimental cutaneous C albicans infection the mRNA expression levels of interleukin (IL)-1a, IL-1beta, IL-8, GM-CSF, Exodus-2, tumour necrosis factor-alpha and PSL (P-selectin ligand) were upregulated. Cytokine profile and histological features of infected skin (separation of keratinocytes, oedema, vacuolisation) were comparable to that seen in experimental contact dermatitis. These immunomodulatory and morphological similarities might reflect a common pathogenesis factor in both diseases.  (+info)

Apolipoprotein E gene polymorphism and serum lipids in patients with superficial fungal disease. (8/55)

Superficial mycosis, including dermatophytic infections, tinea versicolor, and cutaneous candidiasis is mostly limited to the outer layers of the skin, nails, and mucous membranes. In this study, Apolipoprotein E (ApoE) polymorphism and lipoprotein cholesterol concentrations were compared between 42 patients with superficial fungal disease and 27 control subjects. Both the patients and controls were found to be normolipemic. The patients with superficial fungal disease had significantly higher concentrations of high-density cholesterol (HDL) compared to the control group (p=0.0462). However, there was no difference in the serum triglyceride, low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL) cholesterol concentrations. A significantly higher incidence of heterozygosity E2/3 was found in the patients (p=0.0228), and significantly lower incidence of homozygosity E3/3 in all patients, and those with candidiasis and dermatophytosis (p=0.0139, 0.0194 and 0.0337, respectively) compared to the control group. The E3/4 genotype differences between patients and controls were not statistically significant. There were slight differences in the allele frequencies between the two groups, but these did not reach statistically significant levels. It was concluded that the presence of apoE2/3 genotype, high HDL-cholesterol levels and the absence of apoE3/3 genotype can be regarded as risk factors for superficial fungal disease, especially dermatophytosis.  (+info)

Types of candidiasis:

1. Vulvovaginal candidiasis (VVC): a common infection that affects the vagina and vulva; symptoms include itching, burning, and abnormal discharge.
2. Oral thrush (OT): an infection that affects the mouth, often seen in infants and people with weakened immune systems; symptoms include white patches on the tongue and inside the cheeks.
3. Invasive candidiasis (IC): a severe infection that can spread throughout the body, often seen in people with weakened immune systems, such as those with HIV/AIDS or undergoing chemotherapy; symptoms include fever, chills, and difficulty breathing.
4. Candidal balanitis: an infection of the foreskin and glans of the penis; symptoms include redness, swelling, and pain.
5. Diaper rash: a common skin infection that affects infants who wear diapers; symptoms include redness, swelling, and irritability.

Causes and risk factors:

1. Overgrowth of Candida fungus due to an imbalance of the normal flora.
2. Use of antibiotics or steroids that can disrupt the balance of the body's natural flora.
3. Weakened immune system, such as in people with HIV/AIDS or undergoing chemotherapy.
4. Poor hygiene and sanitation.
5. Diabetes mellitus.
6. Pregnancy.
7. Obesity.

Diagnosis:

1. Physical examination and medical history.
2. Microscopic examination of a scraping or biopsy specimen.
3. Cultures of skin, blood, or other body fluids.
4. Polymerase chain reaction (PCR) or other molecular diagnostic techniques to detect the presence of the fungus.

Treatment:

1. Topical antifungal medications, such as clotrimazole, miconazole, or terbinafine, applied directly to the affected area.
2. Oral antifungal medications, such as fluconazole or itraconazole, for more severe infections or those that do not respond to topical treatment.
3. Antibiotics if there is a secondary bacterial infection.
4. Supportive care, such as pain management and wound care.
5. Proper hygiene and sanitation practices.
6. In severe cases, hospitalization may be necessary for intravenous antifungal medications and close monitoring.

Prevention:

1. Practice good hygiene and sanitation.
2. Avoid sharing personal items, such as towels or clothing.
3. Wash hands before touching the affected area.
4. Keep the affected area clean and dry.
5. Use of antifungal powders or sprays on the affected area.
6. Avoid using harsh soaps or cleansers that can irritate the skin.
7. Wear shoes in public areas to prevent exposure to fungal spores.
8. Avoid sharing bathing or showering facilities with others.
9. Dry thoroughly after bathing or swimming.
10. Use of antifungal medications as a prophylactic measure in high-risk individuals, such as those with weakened immune systems.

It's important to note that the best treatment and prevention strategies will depend on the specific type of fungus causing the infection, as well as the severity and location of the infection. It is essential to consult a healthcare professional for proper diagnosis and treatment.

The infection is usually caused by an overgrowth of Candida, which is a normal flora in the mouth, but can become pathogenic under certain conditions. Risk factors for developing OC include taking antibiotics, wearing dentures, pregnancy, diabetes, and HIV/AIDS.

OC can be diagnosed by examining the mouth and throat with a mirror and torch, as well as through laboratory tests such as cultures or PCR. Treatment typically involves antifungal medication, good oral hygiene practices, and addressing any underlying conditions. In severe cases, hospitalization may be necessary.

Preventative measures include practicing good oral hygiene, avoiding smoking, and managing any underlying medical conditions. In addition, early diagnosis and treatment can help prevent the infection from spreading to other parts of the body, such as the bloodstream or heart.

Causes:
The most common cause of candidiasis is an imbalance in the natural bacteria and yeast that live in and around the vagina. This imbalance can be caused by a variety of factors, including:

* Taking antibiotics, which can kill off the "good" bacteria that keep candida in check
* Pregnancy and menopause, when hormonal changes can lead to an overgrowth of yeast
* Diabetes, which can cause excess sugar in the body that feeds the growth of yeast
* Weakened immune system
* Poor hygiene or poor fitting clothing and underwear that can trap moisture and create a warm environment for yeast to grow.

Symptoms:
The symptoms of candidiasis can vary from person to person, but common signs include:

* Itching, burning, and redness of the vulva and vagina
* A thick, white discharge that looks like cottage cheese and has no odor or a mild, sweet smell
* Pain or discomfort during sex
* Difficulty getting pregnant (infertility) if the infection is severe or recurrent.

Diagnosis:
A healthcare provider can diagnose candidiasis by performing a physical examination and taking a sample of vaginal discharge for testing. The provider may also take a culture of the yeast to determine which type of candida is causing the infection.

Treatment:
Candidiasis can be treated with antifungal medications, such as clotrimazole or terconazole. These medications are available over-the-counter or by prescription and come in creams, tablets, or suppositories. To help clear the infection, treatment may also include:

* Avoiding irritants such as douches, powders, or scented soaps
* Wearing loose-fitting clothing and cotton underwear
* Keeping the genital area clean and dry
* Avoiding sex during treatment

Complications:
If left untreated, candidiasis can lead to complications such as:

* Recurrent infections
* Inflammation of the vulva (vulvodynia)
* Inflammation of the vagina (vaginitis)
* Pain during sex
* Difficulty getting pregnant (infertility)

Prevention:
To prevent candidiasis, women can take the following steps:

* Practice good hygiene by washing the genital area gently with soap and water
* Avoid using douches, powders, or scented soaps
* Wear loose-fitting clothing and cotton underwear
* Change out of wet or sweaty clothes as soon as possible
* Avoid sex during treatment for candidiasis.

Prognosis:
With proper treatment, the prognosis for candidiasis is good. The infection usually clears up within a week or two with antifungal medication. However, recurrent infections can be more difficult to treat and may require longer courses of therapy. In some cases, candidiasis can lead to complications such as inflammation of the vulva or vagina, which can be more challenging to treat.

It is important for women to seek medical attention if they experience any symptoms of candidiasis, as early diagnosis and treatment can help prevent complications and improve outcomes.

Candidiasis, invasive is caused by the overgrowth of Candida in the body, which can occur for a variety of reasons, such as:

* Weakened immune system due to HIV/AIDS, cancer, or medications that suppress the immune system.
* Invasive medical devices, such as central lines or implanted pacemakers.
* Previous history of invasive candidiasis.
* Pregnancy.
* Intravenous drug use.

The symptoms of candidiasis, invasive can vary depending on the organs affected, but may include:

* Fever.
* Chills.
* Shortness of breath.
* Pain in the abdomen or chest.
* Confusion or disorientation.
* Skin rash or lesions.

Diagnosis of candidiasis, invasive is based on a combination of physical examination, medical history, and laboratory tests, such as blood cultures and imaging studies. Treatment typically involves the use of antifungal medications, which may be given intravenously or orally, depending on the severity of the infection. In severe cases, hospitalization may be necessary to monitor and treat the infection.

Prevention of candidiasis, invasive includes:

* Proper hygiene and handwashing practices.
* Avoiding close contact with individuals who have invasive candidiasis.
* Avoiding sharing of personal items, such as toothbrushes or razors.
* Avoiding the use of invasive medical devices, if possible.
* Proper care and maintenance of medical devices.
* Monitoring for signs of infection in individuals with weakened immune systems.

In conclusion, candidiasis, invasive is a serious and potentially life-threatening fungal infection that can affect various organs and systems in the body. Early diagnosis and treatment are crucial to prevent complications and improve outcomes. Proper prevention and control measures can help reduce the risk of developing invasive candidiasis.

The symptoms of candidiasis, cutaneous may include:

* Redness and swelling on the affected area
* Itching and burning sensation
* Thickening and discoloration of the skin
* Cracks or fissures in the skin

Candidiasis, cutaneous can be diagnosed through a physical examination and may require additional tests such as a skin scraping or biopsy to confirm the diagnosis. Treatment typically involves antifungal medications and good wound care. In severe cases, hospitalization may be required.

Prevention is key in avoiding candidiasis, cutaneous. Good hygiene practices such as frequent handwashing, keeping the skin clean and dry, and avoiding sharing personal items can help reduce the risk of infection. Additionally, managing underlying conditions such as diabetes and taking antibiotics only when necessary can also help prevent candidiasis, cutaneous.

Symptoms:

* White patches or lesions on the tongue, inside the cheeks, on the gums, and on the skin folds of the neck, armpits, groin, and under the breasts
* Redness and inflammation around the affected areas
* Itching, burning sensations, and pain in the affected areas
* Thickening and discoloration of the nails
* Bad breath or a "furry" tongue
* Skin cracks and fissures
* Nail brittleness and breaking

Causes:

* Overgrowth of Candida fungus, which is normally present in the body
* Poor oral hygiene
* Smoking
* Diabetes
* Obesity
* Hormonal changes during pregnancy or menopause
* Weakened immune system
* Prolonged use of antibiotics or steroids
* Cancer treatment

Diagnosis:

* Physical examination and observation of the symptoms
* Skin scraping or biopsy to confirm the presence of Candida fungus
* Blood tests to rule out other conditions

Treatment:

* Antifungal medications, such as clotrimazole, miconazole, and terbinafine, to kill the fungus
* Good oral hygiene practices, such as brushing and flossing regularly
* Avoiding smoking and sugar-rich diet
* Keeping the skin dry and clean
* Wearing loose-fitting clothing to reduce skin irritation
* Using a medicated mouthwash to treat oral thrush
* In severe cases, hospitalization may be necessary for intravenous antifungal medication

It is important to note that these are general guidelines and the best course of treatment will depend on the severity and location of the infection. A healthcare professional should always be consulted for proper diagnosis and treatment.

Some common types of pharyngeal diseases include:

1. Pharyngitis: This is an inflammation of the pharynx, often caused by viral or bacterial infections. Symptoms may include sore throat, fever, and difficulty swallowing.
2. Tonsillitis: This is an inflammation of the tonsils, which are small gland-like structures located on either side of the back of the throat. Symptoms may include sore throat, fever, and difficulty swallowing.
3. Adenoiditis: This is an inflammation of the adenoids, which are small gland-like structures located in the back of the nasopharynx. Symptoms may include sore throat, fever, and difficulty breathing through the nose.
4. Epiglottitis: This is an inflammation of the epiglottis, which is a flap-like structure that covers the entrance to the larynx (voice box). Symptoms may include fever, sore throat, and difficulty breathing.
5. Laryngitis: This is an inflammation of the larynx (voice box), often caused by viral or bacterial infections. Symptoms may include hoarseness, loss of voice, and difficulty speaking.
6. Sinusitis: This is an inflammation of the sinuses, which are air-filled cavities located within the skull. Symptoms may include facial pain, headache, and nasal congestion.
7. Otitis media: This is an infection of the middle ear, often caused by viral or bacterial infections. Symptoms may include ear pain, fever, and difficulty hearing.
8. Laryngosporangium: This is a type of fungal infection that affects the larynx (voice box) and is more common in hot and humid climates. Symptoms may include hoarseness, cough, and difficulty speaking.
9. Subglottic stenosis: This is a narrowing of the airway below the vocal cords, which can be caused by inflammation or scarring. Symptoms may include difficulty breathing, wheezing, and coughing.
10. Tracheomalacia: This is a softening of the walls of the trachea (windpipe), which can cause the airway to become narrow and obstructed. Symptoms may include difficulty breathing, wheezing, and coughing.

It's important to note that these are just some of the possible causes of a sore throat and difficulty breathing, and it's always best to consult with a healthcare professional for an accurate diagnosis and appropriate treatment.

1. Gastroesophageal reflux disease (GERD): A condition in which stomach acid flows back up into the esophagus, causing symptoms such as heartburn and difficulty swallowing.
2. Esophagitis: Inflammation of the esophagus, often caused by GERD or infection.
3. Barrett's esophagus: A condition in which the cells lining the esophagus undergo abnormal changes, which can increase the risk of developing esophageal cancer.
4. Esophageal rings and webs: Abnormal bands of tissue that can form in the esophagus and cause difficulty swallowing or chest pain.
5. Achalasia: A condition in which the muscles in the lower esophagus do not function properly, making it difficult to swallow.
6. Esophageal cancer: Cancer that develops in the esophagus, often as a result of chronic inflammation or Barrett's esophagus.
7. Esophageal stricture: A narrowing of the esophagus that can cause difficulty swallowing.
8. Esophageal motility disorders: Disorders that affect the muscles in the esophagus and cause difficulty swallowing or regurgitation of food.
9. Esophageal spasms: Involuntary contractions of the muscles in the esophagus, which can cause difficulty swallowing or chest pain.

Esophageal diseases can be diagnosed through a variety of tests, including endoscopy, barium swallow, and CT scan. Treatment options vary depending on the specific disease and can include medications, surgery, or lifestyle changes such as dietary modifications and weight loss.

Symptoms of fungemia may include fever, chills, night sweats, fatigue, and weight loss. Diagnosis is typically made by drawing blood cultures and performing microbiological tests to identify the presence of fungal organisms in the blood. Treatment typically involves administration of antifungal medications, which can be given intravenously or orally. In severe cases, hospitalization may be necessary to monitor and treat the condition.

In some cases, fungemia can lead to complications such as sepsis, organ failure, and death. Prompt diagnosis and treatment are essential to prevent these outcomes.

Candidemia can cause a range of symptoms, including fever, chills, rapid heart rate, and confusion. In severe cases, it can lead to organ failure and death. Treatment typically involves the use of antifungal medications, and in some cases, hospitalization is necessary to manage the infection and monitor the patient's condition.

Preventative measures to reduce the risk of developing candidemia include proper handwashing and hygiene, avoiding close contact with people who are sick, and ensuring that medical equipment and surfaces are properly cleaned and disinfected. Early detection and treatment can significantly improve outcomes for patients with candidemia.

Examples of AROIs include:

1. Pneumocystis pneumonia (PCP): a type of pneumonia caused by the fungus Pneumocystis jirovecii.
2. Tuberculosis (TB): a bacterial infection that can affect the lungs, brain, or other organs.
3. Toxoplasmosis: an infection caused by the parasite Toxoplasma gondii that can affect the brain, eyes, and other organs.
4. Cryptococcosis: a fungal infection that can affect the lungs, brain, or skin.
5. Histoplasmosis: a fungal infection caused by Histoplasma capsulatum that can affect the lungs, skin, and other organs.
6. Aspergillosis: a fungal infection caused by Aspergillus species that can affect the lungs, sinuses, and other organs.
7. Candidiasis: a fungal infection caused by Candida species that can affect the mouth, throat, vagina, or skin.
8. Kaposi's sarcoma: a type of cancer that is caused by the human herpesvirus 8 (HHV-8) and can affect the skin and lymph nodes.
9. Wasting syndrome: a condition characterized by weight loss, fatigue, and diarrhea.
10. Opportunistic infections that can affect the gastrointestinal tract, such as cryptosporidiosis and isosporiasis.

AROIs are a major cause of morbidity and mortality in individuals with HIV/AIDS, and they can be prevented or treated with antimicrobial therapy, supportive care, and other interventions.

There are several types of vaginitis, including:

1. Bacterial vaginosis (BV): This is the most common type of vaginitis and is caused by an overgrowth of harmful bacteria in the vagina. It can be treated with antibiotics.
2. Yeast infection: This type of vaginitis is caused by a fungal infection, usually caused by the organism Candida. It can be treated with antifungal medications.
3. Trichomoniasis: This is a sexually transmitted infection (STI) caused by the parasite Trichomonas vaginalis. It can be treated with antiparasitic medication.
4. Atrophic vaginitis: This type of vaginitis is caused by hormonal changes and is more common in menopausal women. It can be treated with hormone replacement therapy or other medications.
5. Vaginal lichen sclerosus: This is a chronic condition that causes thickening and inflammation of the vaginal tissues, leading to itching and pain during sex.

Symptoms of vaginitis can include:

* Itching, burning, or soreness in the vagina
* Thick, white discharge that may have a strong odor
* Pain or discomfort during sex
* Redness and swelling of the vulva (the external female genital area)

If you suspect you have vaginitis, it is important to see a healthcare provider for proper diagnosis and treatment. They may perform a physical examination, take a sample of vaginal secretions for testing, and/or perform other diagnostic tests such as a pelvic exam or ultrasound. Treatment will depend on the underlying cause of the condition, but may include antibiotics, antifungal medication, or other medications to relieve symptoms.

Preventing vaginitis involves practicing good hygiene and taking steps to maintain a healthy balance of bacteria in the vagina. This can include:

* Wiping from front to back after using the bathroom to prevent bacteria from the anus entering the vagina
* Avoiding douching, which can disrupt the natural balance of bacteria in the vagina
* Avoiding tight-fitting clothing and underwear that can trap moisture and create an ideal environment for bacteria to grow
* Using mild, fragrance-free soap and water to clean the genital area
* Avoiding using scented products or powders in the genital area
* Getting regular gynecological exams to ensure any underlying conditions are identified and treated promptly.

It is also important to note that vaginitis can be a symptom of other underlying conditions, so if you experience recurring or persistent symptoms, it is important to see a healthcare provider for proper diagnosis and treatment.

1. Tooth decay (cavities): A bacterial infection that causes tooth enamel to break down, leading to holes in the teeth.
2. Periodontal disease: An infection of the gums and bone that support the teeth, caused by bacteria.
3. Gingivitis: Inflammation of the gums, usually caused by poor oral hygiene or smoking.
4. Oral thrush: A fungal infection of the mouth, typically affecting people with weakened immune systems.
5. Herpes simplex virus (HSV) infections: Viral infections that cause sores on the lips, tongue, or gums.
6. Cold sores: Caused by the herpes simplex virus, these are small, painful blisters that appear on the lips, nose, or mouth.
7. Canker sores: Small, shallow ulcers that develop on the inside of the mouth, tongue, lips, or gums.
8. Leukoplakia: A condition where thick, white patches form on the insides of the mouth, usually due to excessive tobacco use or other irritants.
9. Oral cancer: Cancer that develops in any part of the mouth, including the lips, tongue, gums, or throat.
10. Dry mouth (xerostomia): A condition where the mouth does not produce enough saliva, which can increase the risk of tooth decay and other problems.

These are just a few examples of mouth diseases. It's important to maintain good oral hygiene and visit a dentist regularly to help prevent these conditions and ensure early detection and treatment if they do occur.

Causes:

* Prolonged exposure to urine and stool can cause skin irritation and inflammation.
* Inadequate cleaning and drying of the diaper area can lead to bacterial or yeast infections.
* Allergies to the ingredients in the diaper or wipes can also contribute to diaper rash.
* Poorly fitting diapers can cause skin folds to rub and become irritated.

Symptoms:

* Redness and swelling of the skin in the diaper area.
* Small, raised bumps or blisters.
* Discharge or pus-like fluid may be present.
* The skin may feel warm to the touch.
* Babies with diaper rash may be fussy or irritable due to discomfort.

Treatment:

* Keep the diaper area clean and dry to prevent bacterial or yeast infections.
* Use a barrier cream or ointment to protect the skin from further irritation.
* Allow the diaper area to air out whenever possible.
* Avoid using harsh soaps or wipes, as these can further irritate the skin.
* Antifungal or antibiotic creams may be prescribed by a healthcare provider if the rash is infected.

Prevention:

* Change diapers frequently and gently to prevent skin irritation.
* Use a gentle, fragrance-free soap and water to clean the diaper area.
* Allow the diaper area to air out whenever possible.
* Avoid using harsh wipes or creams that can further irritate the skin.

Complications:

* If left untreated, diaper rash can lead to more serious conditions such as skin infections or eczema.
* In rare cases, diaper rash can become infected with bacteria such as E. coli or yeast, which can be dangerous for the baby's health.

It is important to seek medical attention if the baby has any of the following symptoms:

* Fever over 100.4°F (38°C)
* Increased redness or swelling of the skin
* Pus or discharge from the diaper area
* Skin cracks or open sores
* The baby is very fussy or uncomfortable
* The rash does not improve with over-the-counter treatments.

The term "polyendocrinopathy" refers to the involvement of multiple endocrine glands, while "autoimmune" indicates that the disorder is caused by an abnormal immune response against the body's own tissues.

Examples of polyendocrinopathies, autoimmune include:

1. Type 1 diabetes with thyroiditis and adrenal insufficiency
2. Hashimoto's thyroiditis with hypophyseal and adrenal involvement
3. Addison's disease with hypothyroidism and hemolytic anemia
4. Autoimmune polyglandular syndrome type 1 (APS-1) with autoantibodies against multiple endocrine glands
5. Autoimmune polyglandular syndrome type 2 (APS-2) with autoantibodies against thyroid, adrenal, and gonadal glands.

The exact cause of polyendocrinopathies, autoimmune is not fully understood, but it is thought to involve a combination of genetic and environmental factors that trigger an abnormal immune response against endocrine tissues. Treatment varies depending on the specific disorder and may include hormone replacement therapy, immunosuppressive medications, and management of associated symptoms.

Some common types of vaginal diseases include:

1. Vaginitis: This is an inflammation of the vagina, often caused by bacterial or yeast infections. Symptoms can include itching, burning, and discharge.
2. Bacterial vaginosis (BV): This is a condition caused by an imbalance of bacteria in the vagina, which can lead to symptoms such as itching, burning, and a strong fishy odor.
3. Yeast infection: This is a common condition caused by the overgrowth of candida yeast in the vagina, which can cause symptoms such as itching, burning, and thick, white discharge.
4. Trichomoniasis: This is a sexually transmitted infection (STI) caused by a parasite called Trichomonas vaginalis, which can cause symptoms such as itching, burning, and a thick, yellowish discharge.
5. Vulvodynia: This is a chronic pain condition that affects the vulva (the external female genital area), which can cause symptoms such as pain during sex, itching, and burning.
6. Lichen sclerosus: This is a skin condition that affects the vulva and vagina, which can cause symptoms such as itching, burning, and thickening of the skin.
7. Vulvar cancer: This is a rare type of cancer that affects the vulva, which can cause symptoms such as itching, bleeding, and a lump or sore on the vulva.

Treatment for vaginal diseases depends on the underlying cause and can range from antibiotics and antifungal medications to surgery and lifestyle changes. It's important to seek medical attention if you experience any persistent or severe symptoms, as early diagnosis and treatment can help prevent complications and improve outcomes.

The symptoms of aspergillosis depend on the location and severity of the infection. In the lungs, it may cause coughing, fever, chest pain, and difficulty breathing. In the sinuses, it can cause headaches, facial pain, and nasal congestion. In the brain, it can cause seizures, confusion, and weakness.

Aspergillosis is typically diagnosed through a combination of imaging tests such as chest X-rays, CT scans, and MRI scans, along with a biopsy to confirm the presence of Aspergillus fungi.

Treatment of aspergillosis depends on the severity and location of the infection. In mild cases, treatment may involve antifungal medications and supportive care such as oxygen therapy and pain management. In severe cases, treatment may require hospitalization and intravenous antifungal medications.

Preventive measures for aspergillosis include avoiding exposure to dusty or damp environments, managing chronic conditions such as asthma and COPD, and taking antifungal medications as prescribed.

Aspergillosis can be a serious condition, especially in people with weakened immune systems, such as those with cancer, HIV/AIDS, or taking immunosuppressive drugs. In severe cases, aspergillosis can lead to life-threatening complications such as respiratory failure, sepsis, and organ damage.

In conclusion, aspergillosis is a common fungal infection that can affect various parts of the body, and it can be serious and potentially life-threatening, especially in people with weakened immune systems. Early diagnosis and appropriate treatment are essential to prevent complications and improve outcomes.

The symptoms of BV can include:

* A strong, unpleasant odor
* Thin, white or grayish discharge
* Itching or burning sensation in the vagina
* Pain or discomfort during sex

BV is diagnosed through a combination of physical examination and laboratory tests, such as a vaginal swab or fluid sample. Treatment typically involves antimicrobial medications to eradicate the overgrowth of pathogenic bacteria. In some cases, metronidazole, an antibiotic that is effective against anaerobic bacteria, may be prescribed.

Complications of BV can include:

* Pelvic inflammatory disease (PID)
* Ectopic pregnancy
* Miscarriage
* Premature labor

Prevention of BV includes good hygiene practices, such as washing the genital area with mild soap and water, avoiding douching, and wearing breathable clothing. Sexual partners should also be treated to prevent re-infection.

It is important to note that BV is not a sexually transmitted infection (STI), but it can be more common in women who have multiple sexual partners or who have a new sexual partner. It is also more common during pregnancy, and in women with diabetes or HIV/AIDS.

The most common types of mycoses include:

1. Ringworm: This is a common fungal infection that causes a ring-shaped rash on the skin. It can affect any part of the body, including the arms, legs, torso, and face.
2. Athlete's foot: This is a common fungal infection that affects the feet, causing itching, redness, and cracking of the skin.
3. Jock itch: This is a fungal infection that affects the groin area and inner thighs, causing itching, redness, and cracking of the skin.
4. Candidiasis: This is a fungal infection caused by Candida, a type of yeast. It can affect various parts of the body, including the mouth, throat, and vagina.
5. Aspergillosis: This is a serious fungal infection that can affect various parts of the body, including the lungs, sinuses, and brain.

Symptoms of mycoses can vary depending on the type of infection and the severity of the infection. Common symptoms include itching, redness, swelling, and cracking of the skin. Treatment for mycoses usually involves antifungal medications, which can be applied topically or taken orally. In severe cases, hospitalization may be necessary to monitor and treat the infection.

Preventive measures for mycoses include practicing good hygiene, avoiding sharing personal items such as towels and clothing, and using antifungal medications as prescribed by a healthcare professional. Early diagnosis and treatment of mycoses can help prevent complications and reduce the risk of transmission to others.

The most common types of CNS fungal infections include:

1. Meningitis: An inflammation of the membranes that cover the brain and spinal cord, caused by fungi such as Candida, Aspergillus, or Cryptococcus.
2. Encephalitis: An inflammation of the brain tissue itself, caused by fungi such as Histoplasma or Coccidioides.
3. Abscesses: Pocket of pus that form in the brain or spinal cord, caused by bacteria or fungi.
4. Opportunistic infections: Infections that occur in people with compromised immune systems, such as HIV/AIDS patients or those taking immunosuppressive drugs after an organ transplant.

CNS fungal infections can cause a wide range of symptoms, including headache, fever, confusion, seizures, and loss of coordination. They are typically diagnosed through a combination of physical examination, laboratory tests, and imaging studies such as CT or MRI scans.

Treatment of CNS fungal infections usually involves the use of antifungal medications, which can be administered intravenously or orally. The choice of treatment depends on the severity and location of the infection, as well as the patient's overall health status. In some cases, surgery may be necessary to drain abscesses or relieve pressure on the brain.

Prevention of CNS fungal infections is important for individuals at risk, such as those with compromised immune systems or underlying medical conditions. This includes taking antifungal medications prophylactically, avoiding exposure to fungal spores, and practicing good hygiene.

Overall, CNS fungal infections are serious and potentially life-threatening conditions that require prompt diagnosis and treatment. With appropriate management, many patients can recover fully, but delays in diagnosis and treatment can lead to poor outcomes.

Symptoms of neutropenia may include recurring infections, fever, fatigue, weight loss, and swollen lymph nodes. The diagnosis is typically made through a blood test that measures the number of neutrophils in the blood.

Treatment options for neutropenia depend on the underlying cause but may include antibiotics, supportive care to manage symptoms, and in severe cases, bone marrow transplantation or granulocyte-colony stimulating factor (G-CSF) therapy to increase neutrophil production.

1) They share similarities with humans: Many animal species share similar biological and physiological characteristics with humans, making them useful for studying human diseases. For example, mice and rats are often used to study diseases such as diabetes, heart disease, and cancer because they have similar metabolic and cardiovascular systems to humans.

2) They can be genetically manipulated: Animal disease models can be genetically engineered to develop specific diseases or to model human genetic disorders. This allows researchers to study the progression of the disease and test potential treatments in a controlled environment.

3) They can be used to test drugs and therapies: Before new drugs or therapies are tested in humans, they are often first tested in animal models of disease. This allows researchers to assess the safety and efficacy of the treatment before moving on to human clinical trials.

4) They can provide insights into disease mechanisms: Studying disease models in animals can provide valuable insights into the underlying mechanisms of a particular disease. This information can then be used to develop new treatments or improve existing ones.

5) Reduces the need for human testing: Using animal disease models reduces the need for human testing, which can be time-consuming, expensive, and ethically challenging. However, it is important to note that animal models are not perfect substitutes for human subjects, and results obtained from animal studies may not always translate to humans.

6) They can be used to study infectious diseases: Animal disease models can be used to study infectious diseases such as HIV, TB, and malaria. These models allow researchers to understand how the disease is transmitted, how it progresses, and how it responds to treatment.

7) They can be used to study complex diseases: Animal disease models can be used to study complex diseases such as cancer, diabetes, and heart disease. These models allow researchers to understand the underlying mechanisms of the disease and test potential treatments.

8) They are cost-effective: Animal disease models are often less expensive than human clinical trials, making them a cost-effective way to conduct research.

9) They can be used to study drug delivery: Animal disease models can be used to study drug delivery and pharmacokinetics, which is important for developing new drugs and drug delivery systems.

10) They can be used to study aging: Animal disease models can be used to study the aging process and age-related diseases such as Alzheimer's and Parkinson's. This allows researchers to understand how aging contributes to disease and develop potential treatments.

Examples of OIs include:

1. Pneumocystis pneumonia (PCP): A type of pneumonia caused by the fungus Pneumocystis jirovecii, which is commonly found in the lungs of individuals with HIV/AIDS.
2. Cryptococcosis: A fungal infection caused by Cryptococcus neoformans, which can affect various parts of the body, including the lungs, central nervous system, and skin.
3. Aspergillosis: A fungal infection caused by Aspergillus fungi, which can affect various parts of the body, including the lungs, sinuses, and brain.
4. Histoplasmosis: A fungal infection caused by Histoplasma capsulatum, which is commonly found in the soil and can cause respiratory and digestive problems.
5. Candidiasis: A fungal infection caused by Candida albicans, which can affect various parts of the body, including the skin, mouth, throat, and vagina.
6. Toxoplasmosis: A parasitic infection caused by Toxoplasma gondii, which can affect various parts of the body, including the brain, eyes, and lymph nodes.
7. Tuberculosis (TB): A bacterial infection caused by Mycobacterium tuberculosis, which primarily affects the lungs but can also affect other parts of the body.
8. Kaposi's sarcoma-associated herpesvirus (KSHV): A viral infection that can cause various types of cancer, including Kaposi's sarcoma, which is more common in individuals with compromised immunity.

The diagnosis and treatment of OIs depend on the specific type of infection and its severity. Treatment may involve antibiotics, antifungals, or other medications, as well as supportive care to manage symptoms and prevent complications. It is important for individuals with HIV/AIDS to receive prompt and appropriate treatment for OIs to help prevent the progression of their disease and improve their quality of life.

There are many different types of vaginal discharge, each with its own characteristics and potential causes. Some common types of vaginal discharge include:

* White, cloudy discharge: This is the most common type of vaginal discharge, and it is usually a sign of a healthy menstrual cycle.
* Clear or light yellow discharge: This type of discharge is often seen during pregnancy or when taking certain medications.
* Thick, white discharge: This type of discharge can be a sign of a yeast infection.
* Frothy, bubbly discharge: This type of discharge can be a sign of a sexually transmitted infection (STI).

Causes of abnormal vaginal discharge include:

* Infections such as bacterial vaginosis or yeast infections
* STIs such as chlamydia or gonorrhea
* Hormonal changes during pregnancy or menopause
* Allergies or sensitivities to certain products, such as soaps or douches
* Certain medications, such as antidepressants or blood pressure medications.

Treatment for abnormal vaginal discharge depends on the underlying cause. In some cases, antibiotics may be prescribed to treat an infection. In other cases, over-the-counter medications such as yeast infection creams or suppositories may be recommended. It is important to see a healthcare provider if you experience any abnormal vaginal discharge, as it can be a sign of a more serious underlying condition.

Here are some examples of splenic diseases:

1. Enlarged Spleen (Splenomegaly): This can be caused by various conditions such as viral infections, malaria, and certain autoimmune disorders. An enlarged spleen can cause abdominal pain, fatigue, and difficulty breathing.
2. Sickle Cell Disease: This is a genetic disorder that affects the production of hemoglobin, leading to anemia and the formation of sickle-shaped red blood cells. The spleen becomes enlarged as it tries to filter out these abnormal cells.
3. Thalassemia: This is another genetic disorder that affects the production of hemoglobin, leading to anemia and the formation of abnormal red blood cells. The spleen can become enlarged in people with thalassemia.
4. Splenic Infarction: This occurs when there is a blockage of blood flow to the spleen, causing tissue death. It can be caused by various conditions such as blood clots, injury, or infection.
5. Splenic Cysts: These are fluid-filled sacs that develop within the spleen. They can be benign or malignant and can cause abdominal pain, bleeding, and other symptoms.
6. Splenic Tumors: These are abnormal growths of tissue in the spleen. They can be benign or malignant and can cause a variety of symptoms depending on their size and location.
7. Splenic Abscess: This is a collection of pus within the spleen, usually caused by an infection. It can cause fever, chills, and abdominal pain.
8. Splenectomy: This is the surgical removal of the spleen, often necessary for conditions such as enlarged spleens or cancerous tumors.
9. Trauma: The spleen can be injured by trauma to the abdomen, such as a car accident or fall. This can cause internal bleeding and other complications.
10. Infection: The spleen can become infected by bacteria, viruses, or other pathogens, leading to symptoms such as fever, chills, and abdominal pain.

It is important to note that some of these conditions can be serious and even life-threatening, so it is important to seek medical attention if you experience any symptoms that may be related to the spleen.

Hairy leukoplakia typically affects people who have a compromised immune system, such as those with HIV/AIDS or taking immunosuppressive medications. It is more common in people who are older and in those who have been infected with the human papillomavirus (HPV).

The main symptom of hairy leukoplakia is the appearance of white patches on the tongue and inside of the cheeks. These patches may be flat or raised, and they can be accompanied by hair-like projections. The patches may also be painful or tender to the touch. In some cases, the condition may cause difficulty swallowing or speaking.

The diagnosis of hairy leukoplakia is usually made based on a physical examination of the mouth and tongue. A biopsy may be performed to confirm the diagnosis and rule out other conditions. Treatment for hairy leukoplakia typically involves addressing any underlying conditions, such as HIV/AIDS or immunosuppressive medications. Antiviral medications may also be prescribed to treat the condition. In some cases, surgery may be necessary to remove the affected areas.

In conclusion, hairy leukoplakia is a condition that affects people with compromised immune systems and is characterized by white patches on the tongue and inside of the cheeks, accompanied by hair-like projections. It can be caused by HIV/AIDS or other conditions that weaken the immune system, and treatment typically involves addressing any underlying conditions and may involve antiviral medications or surgery.

1. Vaginal itching, burning, or soreness
2. A thick, frothy, yellow-green discharge with a strong odor
3. Painful urination
4. Pain during sex
5. Abdominal cramps

Trichomoniasis is usually diagnosed through a physical examination and microscopic examination of vaginal secretions. Treatment involves the use of antiparasitic medications, such as metronidazole or tinidazole, which are effective in clearing the infection. It is important to treat the infection promptly, as untreated trichomoniasis can lead to complications, such as pelvic inflammatory disease (PID) and increased risk of HIV transmission.

Prevention of trichomoniasis includes:

1. Safe sex practices, such as using condoms and dental dams
2. Avoiding sexual contact during outbreaks
3. Proper hygiene and drying of the genital area after sexual activity
4. Avoiding sharing of sexual devices
5. Regular screening for STIs

Trichomoniasis is a common infection that can have serious complications if left untreated. It is important to practice safe sex and seek medical attention if symptoms persist or worsen over time.

There are several types of disease susceptibility, including:

1. Genetic predisposition: This refers to the inherent tendency of an individual to develop a particular disease due to their genetic makeup. For example, some families may have a higher risk of developing certain diseases such as cancer or heart disease due to inherited genetic mutations.
2. Environmental susceptibility: This refers to the increased risk of developing a disease due to exposure to environmental factors such as pollutants, toxins, or infectious agents. For example, someone who lives in an area with high levels of air pollution may be more susceptible to developing respiratory problems.
3. Lifestyle susceptibility: This refers to the increased risk of developing a disease due to unhealthy lifestyle choices such as smoking, lack of exercise, or poor diet. For example, someone who smokes and is overweight may be more susceptible to developing heart disease or lung cancer.
4. Immune system susceptibility: This refers to the increased risk of developing a disease due to an impaired immune system. For example, people with autoimmune disorders such as HIV/AIDS or rheumatoid arthritis may be more susceptible to opportunistic infections.

Understanding disease susceptibility can help healthcare providers identify individuals who are at risk of developing certain diseases and provide preventive measures or early intervention to reduce the risk of disease progression. Additionally, genetic testing can help identify individuals with a high risk of developing certain diseases, allowing for earlier diagnosis and treatment.

In summary, disease susceptibility refers to the predisposition of an individual to develop a particular disease or condition due to various factors such as genetics, environment, lifestyle choices, and immune system function. Understanding disease susceptibility can help healthcare providers identify individuals at risk and provide appropriate preventive measures or early intervention to reduce the risk of disease progression.

1. Cutaneous fusariosis: This type of infection affects the skin and subcutaneous tissues, causing ulcers, nodules, and plaques.
2. Osteoarticular fusariosis: This type of infection affects the bones and joints, causing pain, swelling, and limited mobility.
3. Fusariosis sinusitis: This type of infection affects the paranasal sinuses and can cause chronic rhinosinusitis, meningitis, and ocular involvement.
4. Fusariosis pneumonia: This type of infection affects the lungs and can cause fever, cough, and difficulty breathing.
5. Fusariosis disseminated: This type of infection affects multiple organs and tissues, including the skin, bones, joints, lungs, and central nervous system.

The signs and symptoms of fusariosis can vary depending on the severity and location of the infection, but common symptoms include:

* Skin lesions such as ulcers, nodules, and plaques
* Joint pain and swelling
* Bone pain and limited mobility
* Fever
* Cough
* Difficulty breathing
* Headache
* Fatigue
* Weight loss

The diagnosis of fusariosis is based on a combination of clinical findings, laboratory tests, and imaging studies. Laboratory tests may include:

* Blood cultures: to isolate the fungus from the blood
* Skin or tissue biopsy: to confirm the presence of the fungus in the affected tissue
* Imaging studies such as X-rays, CT scans, or MRI scans: to evaluate the extent of the infection

Treatment of fusariosis is challenging and requires a multidisciplinary approach. The primary goal of treatment is to manage symptoms, prevent complications, and improve quality of life. Treatment options include:

* Antifungal medications: to target the fungus and prevent its growth
* Pain management: to control pain and discomfort
* Wound care: to promote healing of skin lesions and prevent further injury
* Physical therapy: to maintain joint mobility and strength
* Respiratory support: to manage respiratory symptoms
* Nutritional support: to ensure adequate nutrition and hydration

The prognosis for patients with fusariosis is generally poor, with high mortality rates reported in some cases. However, with early diagnosis, appropriate treatment, and close monitoring, some patients may experience improved symptoms and quality of life. It is important to note that the risk of recurrence is high in patients with fusariosis, and ongoing management and surveillance are often necessary to prevent further infections.

Prevention of fusariosis is challenging, but some measures can be taken to reduce the risk of infection. These include:

* Avoiding exposure to fungal spores
* Practicing good wound care and hygiene
* Avoiding immunosuppressive medications whenever possible
* Monitoring for signs of infection and seeking medical attention promptly if symptoms develop

Overall, fusariosis is a severe and potentially life-threatening infection that requires prompt diagnosis and appropriate treatment. With early intervention and ongoing management, some patients may experience improved outcomes and quality of life.

The symptoms of cryptococcosis vary depending on the location and severity of the infection. In lung infections, patients may experience fever, cough, chest pain, and difficulty breathing. In CNS infections, patients may experience headaches, confusion, seizures, and loss of coordination. Skin infections can cause skin lesions, and eye infections can cause vision problems.

Cryptococcosis is diagnosed by culturing the fungus from body fluids or tissue samples. Treatment typically involves antifungal medications, such as amphotericin B or fluconazole, which may be given intravenously or orally, depending on the severity and location of the infection. In severe cases, surgery may be required to remove infected tissue or repair damaged organs.

Preventive measures for cryptococcosis include avoiding exposure to fungal spores, practicing good hygiene, and maintaining a healthy immune system. For individuals with HIV/AIDS, antiretroviral therapy can help reduce the risk of developing cryptococcosis.

Overall, while rare, cryptococcosis is a serious opportunistic infection that can affect individuals with compromised immune systems. Early diagnosis and prompt treatment are essential to prevent complications and improve outcomes.

Also known as:

* Denture stomatitis
* Mucositis
* Gingivostomatitis

Causes and risk factors:

* Ill-fitting dentures
* Poor dental hygiene
* Smoking
* Diabetes
* AIDS
* Old age

Symptoms:

* Pain or discomfort in the mouth
* Ulcers on the gums and inner cheeks
* Difficulty eating or speaking
* Redness and swelling of the gums

Diagnosis:

* Physical examination of the mouth and dentures
* Medical history review
* Blood tests to rule out underlying conditions

Treatment:

* Fitting a new denture or relining the existing one to improve fit
* Improving dental hygiene habits
* Antibiotics for bacterial infections
* Pain relief medication

Prevention:

* Regular dental check-ups and cleaning of dentures
* Proper fit and maintenance of dentures
* Good oral hygiene practices

Note that this is a general overview of the topic, and it's always best to consult with a medical professional for specific advice.

This condition can be caused by various factors such as genetic mutations, infections, autoimmune disorders, and certain medications. In severe cases, agranulocytosis can lead to life-threatening infections that require prompt medical treatment.

Some of the common symptoms of agranulocytosis include fever, chills, sore throat, fatigue, and recurring infections. Diagnosis is typically made through blood tests that measure the number and function of white blood cells, including granulocytes. Treatment options for agranulocytosis depend on the underlying cause, but may include antibiotics, antiviral medications, and immunoglobulin replacement therapy in severe cases.

Types of fungal lung diseases include:

1. Aspergillosis: This is an infection caused by the fungus Aspergillus, which is commonly found in soil and decaying organic matter. It can affect people with weakened immune systems, such as those with cancer, HIV/AIDS, or taking immunosuppressive drugs.
2. Cryptococcosis: This is an infection caused by the fungus Cryptococcus neoformans, which is found in soil and decaying wood. It can affect people with weakened immune systems, such as those with HIV/AIDS or taking immunosuppressive drugs.
3. Histoplasmosis: This is an infection caused by the fungus Histoplasma capsulatum, which is found in soil and decaying organic matter. It can affect people with weakened immune systems, such as those with HIV/AIDS or taking immunosuppressive drugs.
4. Pneumocystis pneumonia (PCP): This is an infection caused by the fungus Pneumocystis jirovecii, which is found in soil and decaying organic matter. It can affect people with weakened immune systems, such as those with HIV/AIDS or taking immunosuppressive drugs.
5. Sporotrichosis: This is an infection caused by the fungus Sporothrix schenckii, which is found in soil and decaying organic matter. It can affect people with weakened immune systems, such as those with HIV/AIDS or taking immunosuppressive drugs.

Symptoms of fungal lung diseases can include:

* Cough
* Fever
* Chest pain
* Shortness of breath
* Fatigue

Diagnosis of fungal lung diseases is typically made through a combination of physical examination, medical history, and laboratory tests such as chest X-rays, CT scans, and fungal cultures. Treatment usually involves antifungal medications and may also include supportive care to manage symptoms.

Prevention of fungal lung diseases includes:

1. Avoiding exposure to fungal spores by wearing protective clothing and gear when working with soil or decaying organic matter.
2. Maintaining good indoor air quality by using ventilation systems and reducing humidity.
3. Reducing the risk of infection by avoiding close contact with people who are at high risk of developing fungal lung diseases, such as those with weakened immune systems.
4. Avoiding smoking and other tobacco products, which can increase the risk of developing fungal lung diseases.
5. Managing underlying medical conditions, such as HIV/AIDS or taking immunosuppressive drugs, to reduce the risk of developing fungal lung diseases.

There are many different types of stomach diseases, some of which include:

1. Gastritis: This is inflammation of the stomach lining, which can be caused by infection, autoimmune disorders, or excessive alcohol consumption.
2. Peptic ulcer: This is a sore on the lining of the stomach or duodenum (the first part of the small intestine). Peptic ulcers are often caused by infection with the bacterium Helicobacter pylori, but they can also be caused by excessive acid production.
3. Gastroesophageal reflux disease (GERD): This is a condition in which stomach acid flows back up into the esophagus, causing symptoms such as heartburn and difficulty swallowing.
4. Stomach cancer: This is a type of cancer that affects the stomach lining, and it can be caused by a variety of factors including age, diet, and family history.
5. Inflammatory bowel disease (IBD): This is a chronic condition that causes inflammation in the digestive tract, including the stomach. Crohn's disease and ulcerative colitis are examples of IBD.
6. Gastrointestinal motility disorders: These are conditions that affect the muscles and nerves of the digestive system, causing problems with movement and contraction of the stomach and intestines.
7. Stomach polyps: These are growths on the lining of the stomach that can be benign or cancerous.
8. Hiatal hernia: This is a condition in which part of the stomach bulges up into the chest through a hole in the diaphragm, which can cause symptoms such as heartburn and difficulty swallowing.
9. Gastroesophageal reflux disease (GERD): This is a chronic form of acid reflux that can cause symptoms such as heartburn and difficulty swallowing.
10. Zollinger-Ellison syndrome: This is a rare condition that causes the stomach to produce too much acid, leading to symptoms such as heartburn, nausea, and vomiting.

These are just some of the many possible causes of stomach pain. It's important to see a doctor if you experience persistent or severe stomach pain, especially if it is accompanied by other symptoms such as fever, bleeding, or difficulty swallowing. Your doctor can perform tests and examinations to determine the cause of your stomach pain and recommend appropriate treatment.

HIV (human immunodeficiency virus) infection is a condition in which the body is infected with HIV, a type of retrovirus that attacks the body's immune system. HIV infection can lead to AIDS (acquired immunodeficiency syndrome), a condition in which the immune system is severely damaged and the body is unable to fight off infections and diseases.

There are several ways that HIV can be transmitted, including:

1. Sexual contact with an infected person
2. Sharing of needles or other drug paraphernalia with an infected person
3. Mother-to-child transmission during pregnancy, childbirth, or breastfeeding
4. Blood transfusions ( although this is rare in developed countries due to screening processes)
5. Organ transplantation (again, rare)

The symptoms of HIV infection can be mild at first and may not appear until several years after infection. These symptoms can include:

1. Fever
2. Fatigue
3. Swollen glands in the neck, armpits, and groin
4. Rash
5. Muscle aches and joint pain
6. Night sweats
7. Diarrhea
8. Weight loss

If left untreated, HIV infection can progress to AIDS, which is a life-threatening condition that can cause a wide range of symptoms, including:

1. Opportunistic infections (such as pneumocystis pneumonia)
2. Cancer (such as Kaposi's sarcoma)
3. Wasting syndrome
4. Neurological problems (such as dementia and seizures)

HIV infection is diagnosed through a combination of blood tests and physical examination. Treatment typically involves antiretroviral therapy (ART), which is a combination of medications that work together to suppress the virus and slow the progression of the disease.

Prevention methods for HIV infection include:

1. Safe sex practices, such as using condoms and dental dams
2. Avoiding sharing needles or other drug-injecting equipment
3. Avoiding mother-to-child transmission during pregnancy, childbirth, or breastfeeding
4. Post-exposure prophylaxis (PEP), which is a short-term treatment that can prevent infection after potential exposure to the virus
5. Pre-exposure prophylaxis (PrEP), which is a daily medication that can prevent infection in people who are at high risk of being exposed to the virus.

It's important to note that HIV infection is manageable with proper treatment and care, and that people living with HIV can lead long and healthy lives. However, it's important to be aware of the risks and take steps to prevent transmission.

Recurrence can also refer to the re-emergence of symptoms in a previously treated condition, such as a chronic pain condition that returns after a period of remission.

In medical research, recurrence is often studied to understand the underlying causes of disease progression and to develop new treatments and interventions to prevent or delay its return.

Esophagitis can be acute or chronic, and it can affect people of all ages. Acute esophagitis is a short-term inflammation that can be caused by a viral or bacterial infection, while chronic esophagitis can last for weeks or months and may be caused by ongoing exposure to irritants such as stomach acid or allergens.

Esophagitis can lead to complications such as narrowing of the esophagus, stricture, or ulcers, which can make it difficult to swallow and can lead to malnutrition and weight loss. In severe cases, esophagitis can also lead to life-threatening complications such as perforation or bleeding.

Esophagitis is diagnosed through a combination of endoscopy, imaging tests such as CT scans or MRI, and laboratory tests such as blood tests or biopsies. Treatment for esophagitis depends on the underlying cause, but may include antibiotics, anti-inflammatory medications, and lifestyle changes such as avoiding trigger foods or drinks. In severe cases, surgery may be necessary to repair any damage to the esophagus.

Esophagitis is a common condition that affects millions of people worldwide, and it can have a significant impact on quality of life. While there are several effective treatment options available, prevention is often the best approach, and this involves making lifestyle changes such as avoiding trigger foods or drinks, managing gastroesophageal reflux disease (GERD), and practicing good hygiene to avoid infections. With proper diagnosis and treatment, most people with esophagitis can experience significant improvement in symptoms and quality of life.

Other definitions:

* Premature birth: A birth that occurs before 37 completed weeks of gestation.
* Preterm birth: A birth that occurs before 37 completed weeks of gestation, but not necessarily before 22 weeks.
* Very preterm birth: A birth that occurs before 28 completed weeks of gestation.
* Extremely preterm birth: A birth that occurs before 24 completed weeks of gestation.

Diseases associated with premature infants:

1. Respiratory distress syndrome (RDS): A condition in which the baby's lungs do not produce enough surfactant, a substance that helps the air sacs in the lungs expand and contract properly.
2. Bronchopulmonary dysplasia (BPD): A chronic lung disease that can develop in premature infants who have RDS.
3. Intraventricular hemorrhage (IVH): Bleeding in the brain that can occur in premature infants, particularly those with RDS or BPD.
4. Retinopathy of prematurity (ROP): A condition that can cause blindness in premature infants due to abnormal blood vessel growth in the retina.
5. Necrotizing enterocolitis (NEC): A condition that can cause damage to the intestines and other parts of the digestive system in premature infants.
6. Intracranial hemorrhage (ICH): Bleeding in the brain that can occur in premature infants, particularly those with RDS or BPD.
7. Gastrointestinal problems: Premature infants are at risk for gastroesophageal reflux disease (GERD), necrotizing enterocolitis (NEC), and other gastrointestinal problems.
8. Feeding difficulties: Premature infants may have difficulty feeding, which can lead to weight gain issues or the need for a feeding tube.
9. Respiratory infections: Premature infants are at increased risk for respiratory infections, such as pneumonia and bronchiolitis.
10. Developmental delays: Premature infants may be at risk for developmental delays or learning disabilities, particularly if they experienced significant health problems or required oxygen therapy.

It is important to note that not all premature infants will develop these complications, and the severity of the conditions can vary depending on the individual baby's health and the level of care they receive. However, it is essential for parents and caregivers to be aware of the potential risks and seek prompt medical attention if they notice any signs of distress or illness in their premature infant.

Types of Gastrointestinal Diseases:

1. Irritable Bowel Syndrome (IBS): A common condition characterized by abdominal pain, bloating, and changes in bowel movements.
2. Inflammatory Bowel Disease (IBD): A group of chronic conditions that cause inflammation in the digestive tract, including Crohn's disease and ulcerative colitis.
3. Gastroesophageal Reflux Disease (GERD): A condition in which stomach acid flows back into the esophagus, causing heartburn and other symptoms.
4. Peptic Ulcer Disease: A condition characterized by ulcers in the lining of the stomach or duodenum.
5. Diverticulitis: A condition in which small pouches form in the wall of the colon and become inflamed.
6. Gastritis: Inflammation of the stomach lining, often caused by infection or excessive alcohol consumption.
7. Esophagitis: Inflammation of the esophagus, often caused by acid reflux or infection.
8. Rectal Bleeding: Hemorrhage from the rectum, which can be a symptom of various conditions such as hemorrhoids, anal fissures, or inflammatory bowel disease.
9. Functional Dyspepsia: A condition characterized by recurring symptoms of epigastric pain, bloating, nausea, and belching.
10. Celiac Disease: An autoimmune disorder that causes the immune system to react to gluten, leading to inflammation and damage in the small intestine.

Causes of Gastrointestinal Diseases:

1. Infection: Viral, bacterial, or parasitic infections can cause gastrointestinal diseases.
2. Autoimmune Disorders: Conditions such as Crohn's disease and ulcerative colitis occur when the immune system mistakenly attacks healthy tissue in the GI tract.
3. Diet: Consuming a diet high in processed foods, sugar, and unhealthy fats can contribute to gastrointestinal diseases.
4. Genetics: Certain genetic factors can increase the risk of developing certain gastrointestinal diseases.
5. Lifestyle Factors: Smoking, excessive alcohol consumption, stress, and lack of physical activity can all contribute to gastrointestinal diseases.
6. Radiation Therapy: Exposure to radiation therapy can damage the GI tract and increase the risk of developing certain gastrointestinal diseases.
7. Medications: Certain medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids can cause gastrointestinal side effects.

A type of meningitis caused by a fungal infection. Fungal meningitis is a serious and potentially life-threatening condition that can occur when fungi enter the bloodstream and spread to the membranes surrounding the brain and spinal cord (meninges).

The most common types of fungi that cause fungal meningitis are Aspergillus, Candida, and Cryptococcus. These fungi can be found in soil, decaying organic matter, and contaminated food. People with weakened immune systems, such as those with HIV/AIDS or taking immunosuppressive drugs, are at a higher risk of developing fungal meningitis.

Symptoms of fungal meningitis may include fever, headache, stiff neck, sensitivity to light, and confusion. If left untreated, fungal meningitis can lead to serious complications such as brain damage, hearing loss, and seizures. Treatment typically involves the use of antifungal medications, and in severe cases, surgery may be necessary to remove infected tissue or relieve pressure on the brain.

Preventive measures for fungal meningitis include avoiding exposure to fungal sources, practicing good hygiene, and taking antifungal medications as prescribed by a healthcare professional. Early diagnosis and treatment are critical in preventing serious complications and improving outcomes for patients with fungal meningitis.

Here are some common types of tongue diseases:

1. Oral thrush: A fungal infection that causes white patches on the tongue and inner cheeks.
2. Candidiasis: A fungal infection that can cause redness, irritation, and cracks on the tongue.
3. Lichen planus: An autoimmune condition that leads to inflammation and lesions on the tongue.
4. Leukoplakia: A condition characterized by thick, white patches on the tongue that can be caused by smoking or other irritants.
5. Erthyema migrans: A condition that causes a red, itchy rash on the tongue and other parts of the body.
6. Cancer: Malignant tumors can occur on the tongue, which can be benign or malignant.
7. Melanosis: A condition characterized by dark spots or patches on the tongue.
8. Median rhomboid glossitis: An inflammatory condition that affects the tongue and can cause pain, redness, and swelling.
9. Gingivostomatitis: An inflammation of the gums and tongue that can be caused by bacterial or viral infections.
10. Hairy tongue: A condition characterized by long, hair-like projections on the surface of the tongue.

Treatment for tongue diseases depends on the underlying cause and can range from antifungal medications to surgery. In some cases, tongue diseases may be a sign of an underlying health issue, such as a weakened immune system or a nutrient deficiency. It is essential to consult a healthcare professional for proper diagnosis and treatment.

... is a type of candida infection in newborn babies, which appears as generalized red patches and ... Skoczylas, MM; Walat, A; Kordek, A; Loniewska, B; Rudnicki, J; Maleszka, R; Torbé, A (2014). "Congenital candidiasis as a ... ISBN 0-7216-2921-0. v t e (Articles with short description, Short description matches Wikidata, Mycosis-related cutaneous ... conditions, All stub articles, Infection-related cutaneous condition stubs). ...
Yusuf Ibrahim (doctor), Egyptian physician known for Congenital cutaneous candidiasis. Zaha Hadid, world-renowned Iraqi-British ...
... is a skin condition, an id reaction, similar to dermatophytids.: 311 Candidiasis List of cutaneous conditions James WD ... ISBN 978-0-7216-2921-6. v t e (Articles with short description, Short description matches Wikidata, Mycosis-related cutaneous ... conditions, All stub articles, Infection-related cutaneous condition stubs). ...
In other countries, it is used to treat cutaneous candidiasis, dermatophytosis, pityriasis versicolor. Itoyama T, Aoki Y, ...
They can also be used for the treatment of cutaneous candidiasis and pityriasis versicolor. The medication is sometimes ... Oral Candidiasis (Oral Thrush) Nystatin is commonly used in treatment of lesions of the mouth caused by oral candidiasis. The ... It can also be used to treat vaginal and vulval candidiasis by administering creams or pessaries vaginally. Some patients may ... Miconazole can also be used for both prevention and treatment of oral candidiasis which the drug is formulated as oromucosal ...
He was responsible for the description of congenital cutaneous candidiasis, originally known as Beck-Ibrahim disease. The ...
Examples of dermatomycosis are tinea and cutaneous candidiasis.These fungal infections impair superficial layers of the skin, ...
Applied to the skin it is used for fungal skin infections such as tinea, cutaneous candidiasis, pityriasis versicolor, dandruff ... Gupta AK, Lyons DC (2015). "The Rise and Fall of Oral Ketoconazole". Journal of Cutaneous Medicine and Surgery. 19 (4): 352-7. ... candidiasis (yeast infection or thrush), jock itch, and tinea versicolor. Topical ketoconazole is also used as a treatment for ...
Candidiasis Skin lesion James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: clinical ... v t e (Articles with short description, Short description matches Wikidata, Mycosis-related cutaneous conditions, All stub ... A., Chiriac; P., Pinteala Foia; P., Brzezinskki (2014). "Erosio blastomycetica interdigitale sign of Candidiasis and diabetes ... A review of interdigital candidiasis". Dermatology Online Journal. 24 (8). doi:10.5070/D3248041124. PMID 30677843. ...
"Candidiasis". Centers for Disease Control and Prevention. Archived from the original on 2013-04-19. Retrieved 2013-04-25. " ... Nenoff, P.; Krüger, C.; Mayser, P. (2015-06-01). "[Cutaneous Malassezia infections and Malassezia associated dermatoses: An ... Candidiasis). The site at which a microbe enters the body is referred to as the portal of entry. These include the respiratory ...
Candidiasis List of cutaneous conditions ^ Indicates 9 references to specific, numbered pages in the Online Mendelian ... "Orphanet: Chronic mucocutaneous candidiasis". www.orpha.net. Retrieved 2017-06-09. "Candidiasis familial chronic mucocutaneous ... Chronic mucocutaneous candidiasis is an immune disorder of T cells. It is characterized by chronic infections with Candida that ... Chronic mucocutaneous candidiasis mutations affect IL-17 by inhibiting its pathway. This in turn affects the human immune ...
If an infection involves interdigital candidiasis, paronychia and diaper rash, subject is likely to have cutaneous candidiasis ... Usage of caspofungin will efficiently target against oropharyngeal and oesophgeal candidiasis and invasive candidiasis. ... invasive and disseminated candidiasis, gastrointestinal candidiasis and candidemia. C. tropicalis colonization is favoured in ... Impact of candidiasis, infections cause by C. tropicalis, have increased globally. C. tropicalis is virulent due to its ability ...
... without signs of candidiasis on other mucosal or cutaneous sites. The lesions are variably red and/or white. Unusually for ... Unlike other forms of candidiasis, hyperplastic candidiasis may show dysplasia. Oral candidiasis can be treated with topical ... "plaque-like candidiasis" or "nodular candidiasis". The most common appearance of hyperplastic candidiasis is a persistent white ... a secondary oral candidiasis). These include Localized chronic mucocutaneous candidiasis, diffuse mucocutaneous candidiasis ( ...
Gastrointestinal candidiasis Respiratory candidiasis Cutaneous candidiasis Candidal folliculitis Candidal intertrigo Candidal ... Mucosal candidiasis Oral candidiasis (thrush, oropharyngeal candidiasis) Pseudomembranous candidiasis Erythematous candidiasis ... 309 Candidid Chronic mucocutaneous candidiasis Congenital cutaneous candidiasis Diaper candidiasis: an infection of a child's ... Vaginal candidiasis can cause congenital candidiasis in newborns. In oral candidiasis, simply inspecting the person's mouth for ...
Congenital cutaneous candidiasis Cryptococcosis Dermatophytid Diaper candidiasis Disseminated coccidioidomycosis (coccidioidal ... Cutaneous ciliated cyst Cutaneous columnar cyst Cutaneous horn (Cornu cutaneum) Cystic basal cell carcinoma Dermal eccrine ... Primary cutaneous immunocytoma Primary cutaneous marginal zone lymphoma Retiform parapsoriasis Secondary cutaneous CD30+ large ... Cutaneous group B streptococcal infection Cutaneous Pasteurella hemolytica infection Cutaneous Streptococcus iniae infection ...
... candidiasis, chronic mucocutaneous MeSH C01.703.160.170 - candidiasis, cutaneous MeSH C01.703.160.180 - candidiasis, oral MeSH ... candidiasis, chronic mucocutaneous MeSH C01.539.800.200.105 - candidiasis, cutaneous MeSH C01.539.800.200.110 - ... candidiasis, chronic mucocutaneous MeSH C01.703.295.170 - candidiasis, cutaneous MeSH C01.703.295.182 - chromoblastomycosis ... cutaneous MeSH C01.252.825.820 - tuberculosis, cutaneous MeSH C01.252.825.820.260 - erythema induratum MeSH C01.252.825.820.470 ...
Erythrasma Balanoposthitis Fournier's Gangrene Candidiasis Tinea cruris Cutaneous larva migrans Pubic lice Scabies Tick ...
... doctor partially responsible for the description of congenital cutaneous candidiasis, who was also implicated in the Nazi ...
... candidiasis, chronic mucocutaneous MeSH C17.800.838.208.170 - candidiasis, cutaneous MeSH C17.800.838.208.241 - ... cutaneous MeSH C17.800.838.765.820 - tuberculosis, cutaneous MeSH C17.800.838.765.820.320 - erythema induratum MeSH C17.800. ... cutaneous MeSH C17.800.838.775.560.400.350 - leishmaniasis, diffuse cutaneous MeSH C17.800.838.775.560.400.385 - leishmaniasis ... cutaneous MeSH C17.800.508.473.500 - urticaria pigmentosa MeSH C17.800.529.400 - nail-patella syndrome MeSH C17.800.529.406 - ...
... and newly discovered cases of cutaneous, ocular and osteoarticular manifestations of candidiasis in young heroin addicts. ... The cases included a wide range of mycoses such as candidiasis, histoplasmosis, African blastomycosis, mycetoma, fungal ... Cutaneous disseminated mycosis in a patient with AIDS due to a new dimorphic fungus. Journal de mycologie médicale, 8(2), 57-63 ...
ISBN 0-7216-2921-0. v t e (Articles with short description, Short description matches Wikidata, Mycosis-related cutaneous ... 309 Candidiasis Intertrigo Skin lesion James, William D.; Berger, Timothy G.; et al. (2006). Andrews' Diseases of the Skin: ... conditions, All stub articles, Infection-related cutaneous condition stubs). ...
Oral candidiasis, also commonly referred to as oral thrush, is a fungal infection caused mainly by Candida albicans, which ... Virus-related cutaneous conditions caused by these obligate intracellular agents derive from both DNA and RNA viruses. Some ... Soenjoyo KR, Chua BW, Wee LW, Koh MJ, Ang SB (November 2020). "Treatment of cutaneous viral warts in children: A review". ... Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA (January 2020). "Oral Candidiasis: A Disease of Opportunity". Journal ...
Diseases caused by funguses include candidiasis cryptococcosis facial eczema fungal placentitis sporotrichosis zygomycosis ... also known as cutaneous streptothricosis, rainscald, rain rot, lumpy wool, or strawberry footrot ehrlichiosis enterotoxemia ...
Cutaneous: chloasma or melasma (which may continue despite discontinuation of the drug), erythema multiforme, erythema nodosum ... vaginitis including vaginal candidiasis, changes in cervical secretion and cervical ectropion, ovarian cancer, endometrial ...
List of cutaneous conditions James WD, Berger T, Elston D (2006). Andrews' Diseases of the Skin: Clinical Dermatology (10th ed ... candidiasis, frictional or contact dermatitis, and inverse psoriasis. A biopsy and/or family history can confirm. The lack of ...
Affected infants typically develop chronic diarrhea, a fungal infection in the mouth called oral thrush (candidiasis), ... List of cutaneous conditions Notarangelo, L. D.; Mella, P.; Jones, A.; de Saint Basile, G.; Savoldi, G.; Cranston, T.; Vihinen ...
Vaginal candidiasis can very rarely cause congenital candidiasis in newborns. Infection occurs in about 30% of women who are ... Mycosis-related cutaneous conditions, Wikipedia medicine articles ready to translate, Vagina, Fungal diseases). ... Candidiasis is one of the three most common vaginal infections along with bacterial vaginosis and trichomonas. About 75% of ... "Vaginal Candidiasis , Fungal Diseases , CDC". www.cdc.gov. 2020-11-10. Retrieved 2021-01-16. Roberts, CL; Algert, CS; Rickard, ...
It may also be used to prevent candidiasis in those who are at high risk. Nystatin may be used by mouth, in the vagina, or ... On occasion,[which?] serum levels of the drug can be identified from oral, vaginal, or cutaneous administration, and lead to ... It is effective in treating oral candidiasis in elderly people who wear dentures. It is also used in very low birth-weight ( ... Lyu, Xin; Zhao, Chen; Yan, Zhi-Min; Hua, Hong (2016). "Efficacy of nystatin for the treatment of oral candidiasis: a systematic ...
List of cutaneous conditions Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. ... candidiasis or tinea. Drugs including finasteride, etizolam (and benzodiazepines), chloroquine, hydroxychloroquine, oestrogen, ...
Oral candidiasis may develop with long term topical steroid use, and sometimes antimycotics such as miconazole gel or ... Gestational pemphigoid List of cutaneous conditions List of target antigens in pemphigoid List of immunofluorescence findings ... Chronic blistering cutaneous conditions, Autoimmune diseases, Oral mucosal pathology). ...
Cutaneous anthrax Cutaneous larva migrans Cutaneous lupus erythematosus Cutaneous photosensitivity colitis lethal Cutaneous T- ... Camptodactyly vertebral fusion Campylobacteriosis Camurati-Engelmann disease Canavan leukodystrophy Candidiasis Candidiasis ... cutaneous, articular syndrome Chudley-Lowry-Hoar syndrome Chudley-Rozdilsky syndrome Chudley-Mccullough syndrome Churg-Strauss ... cell lymphoma Cutaneous vascularitis Cutis Gyrata syndrome of Beare and Stevenson Cutis gyratum acanthosis nigricans ...
It is found that cutaneous lichen planus does not carry a risk of skin cancer. In contrast to cutaneous LP, which is self ... Oropharyngeal candidiasis (also known as thrush) is a common infection that has a predilection for infants, older adults with ... Lichen planus may be categorized as affecting mucosal or cutaneous surfaces. Cutaneous forms are those affecting the skin, ... including cutaneous LP, genital LP, nail LP, and lichen planopilaris (scalp LP). Cutaneous LP is a self-limiting condition. It ...
ASPA Candidiasis, familial chronic mucocutaneous, autosomal dominant; 613108; CLEC7A Candidiasis, familial chronic ... primary localized cutaneous; 105250; OSMR Amyloidosis, renal; 105200; LYZ Amyotrophic lateral sclerosis 10, with or without FTD ... WNT4 Multiple cutaneous and uterine leiomyomata; 150800; FH Multiple endocrine neoplasia IIA; 171400; RET Multiple endocrine ... cutaneous malignant, 2; 155601; CDKN2A Meleda disease; 248300; SLURP1 Melnick-Needles syndrome; 309350; FLNA Melorheostosis ...
... is easily confused with impetigo and candidiasis. IgG4 is considered pathogenic. The diagnosis can be ... List of conditions caused by problems with junctional proteins List of cutaneous conditions List of immunofluorescence findings ... but also includes cutaneous blisters. Other mucosal surfaces, the conjunctiva, nose, esophagus, penis, vulva, vagina, cervix, ...
... and is able to cause both mild candidiasis in healthy people and severe invasive candidiasis in those who cannot fight ... 2020). "4. Applications of nanometals in cutaneous infections". In Rai M (ed.). Nanotechnology in Skin, Soft Tissue, and Bone ... Some tinea and candidiasis infections of the skin can appear similar to eczema and lichen planus. Pityriasis versicolor can ... Oral candidiasis Tinea corporis Pityriasis versicolor Onychomycosis Subcutaneous fungal infections include sporotrichosis, ...
Fungal infection such as candidiasis is also common due to the immunosuppression required in the treatment of the disease. ... Thrash B, Patel M, Shah KR, Boland CR, Menter A (February 2013). "Cutaneous manifestations of gastrointestinal disease: part II ... An Approach to an Uncommon but Important Cutaneous Disorder". BioMed Research International. 2017: e8192150. doi:10.1155/2017/ ...
Cicatricial alopecia List of cutaneous conditions "OMIM Entry - # 308205 - IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME". ... chronic candidiasis, keratitis, seizures, mental retardation and inguinal hernia: a severe manifestation of IFAP syndrome?, ...
... which may lead to opportunistic infections such as candidiasis.[citation needed] Most of the signs and symptoms of ehrlichiosis ... Bacterium-related cutaneous conditions, Tick-borne diseases). ...
Similarly, cutaneous (skin) conditions can also involve the mouth and sometimes only the mouth, sparing the skin. The different ... or systemic steroids may be used to reduce inflammation An antifungal drug may be used to prevent oral candidiasis developing ... meaning that many gastrointestinal and cutaneous conditions can involve the mouth. Some conditions usually associated with the ... environmental conditions (saliva, thinner mucosa, trauma from teeth and food), mean that some cutaneous disorders which produce ...
Cutaneous candidiasis and other forms of candidosis are infections caused by the yeast Candida albicans or other Candida ... encoded search term (Cutaneous Candidiasis) and Cutaneous Candidiasis What to Read Next on Medscape ... Cutaneous candidiasis and other forms of candidiasis are infections caused by the yeast Candida albicans or other Candida ... Cutaneous Candidiasis. Updated: Jan 17, 2020 * Author: Richard Harold "Hal" Flowers, IV, MD; Chief Editor: Dirk M Elston, MD ...
This child has a large rash caused by candidiasis, affecting the skin around the mouth. There are also other lesions that ... This child has a large rash caused by candidiasis, affecting the skin around the mouth. There are also other lesions that ... Candidiasis, cutaneous - around the mouth. URL of this page: //medlineplus.gov/ency/imagepages/1411.htm Candidiasis, cutaneous ...
Patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy show diverse endocrine and nonendocrine ... candidiasis-ectodermal dystrophy-like kinase-dead Ikkα knockin mice and patients with autoimmune polyendocrinopathy-candidiasis ... Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Ferré EMN, Schmitt MM, Lionakis MS. Ferré EMN, et al. Front ... A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis- ...
Candidiasis is caused by infection with species of the genus Candida, predominantly with Candida albicans. Candida species are ... Cutaneous candidiasis. Most localized cutaneous candidiasis infections may be treated with any number of topical antifungal ... Invasive candidiasis. Empirical treatment options for suspected invasive candidiasis include the following:. * Empirical ... Genitourinary tract candidiasis. Vulvovaginal candidiasis (VVC) can be managed with either topical antifungal agents or a ...
... or vulvovaginal candidiasis? This short study looks at the treatments available, and the best ways to prevent vulvovaginal ... Mucosal Candidiasis * 20021090632-overview. Diseases & Conditions Cutaneous Candidiasis * 20021091928-overview. Diseases & ... What is Vulvovaginal Candidiasis? Some yeast or fungus normally lives in a healthy womans vagina. When there is too much yeast ... Table 1. Recommended Treatment for Vulvovaginal Candidiasis Intravaginal Agents (one of following). Brand Name. Duration. ...
Cutaneous candidiasis, tinea corporis, tinea cruris, tinea pedis, and tinea (pityriasis) versicolor. It is recommended that ... in the treatment of cutaneous candidiasis caused by Candida spp. and in the treatment of seborrheic dermatitis. ...
Candidiasis, Cutaneous / drug therapy* * Candidiasis, Cutaneous / microbiology * Candidiasis, Vulvovaginal / drug therapy * ...
Candidiasis of the Skin (Cutaneous Candidiasis). Medically reviewed by Laura Marusinec, MD ... Candidiasis of the skin is a fungal infection that causes a red, itchy rash. Learn about candidiasis of the skin causes, ...
Skin: Cutaneous candidiasis is a medical term for a yeast infection that affects the skin. Yeast infections can occur on almost ... Flowers RH, Mark E, Wilson BB.. Cutaneous candidiasis workup. In: Elston DM, ed. Medscape. Updated January 17, 2020. Accessed ... Mouth and throat: When Candida yeast infection occurs in the throat or mouth it is called thrush or oropharyngeal candidiasis. ... Yeast infections, also called candidiasis, are very common. Most people with a vagina will have one or more yeast infections ...
Categories: Candidiasis, Cutaneous Image Types: Photo, Illustrations, Video, Color, Black&White, PublicDomain, ...
Chronic complications include mucosal atrophy; mucosal, cutaneous and muscular fibrosis; xerostomia and associated caries; ... Acute complications include oropharyngeal mucositis, sialdenitis and xerostomia, infections (primary candidiasis) and taste ...
Cutaneous candidiasis is called Intertrigo when occurring under heavy skin folds.. You can get a fungal infection by touching a ... Cutaneous candidiasis involves infection of the skin with candida. It may involve almost any skin surface on the body, but ... Antibiotics and oral contraceptives increase the risk of cutaneous candidiasis.. Signs and Symptoms. Fungi are yeasts and molds ... Cutaneous candidiasis is fairly common. Candida is the most common cause of diaper rash in infants where it takes advantage of ...
Treatment of chronic mucocutaneous candidiasis has included drugs, immunotherapy, and replacement of nutritional and endocrine ... Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice. Taudorf EH, ... Chronic mucocutaneous candidiasis. Successful treatment with intermittent oral doses of clotrimazole A S Rockoff. Arch Dermatol ... Clotrimazole: intermittent therapy in chronic mucocutaneous candidiasis. Ipp MM, Boxall L, Gelfand EW. Ipp MM, et al. Am J Dis ...
fungus that most often causes cutaneous candidiasis is Candida albicans . Candida is the most common cause of diaper rash ... ... Candidiasis (VisualDX) ... yeast infection, is an overgrowth of the common Candida albicans fungus, which is naturally found in ... Candidiasis, Diaper Dermatitis (VisualDX) Candidal diaper dermatitis is caused when Candida albicans, a common type of yeast ...
Clinical and mycological spectrum of cutaneous candidiasis in Bombay.. PS Shroff, DA Parikh, RJ Fernandez, UD Wagle. April-June ... A total of 150 patients with cutaneous candidiasis were studied. A detailed clinical history was taken. Scrapings were examined ...
Patient 18 was an infant boy with oral candidiasis, cutaneous manifestations, and failure to thrive. A presumptive diagnosis of ...
Candidiasis, Chronic Mucocutaneous. *Candidiasis, Cutaneous. *Candidiasis, Oral. *Candidiasis, Vulvovaginal. *Facial Dermatoses ...
Candidiasis, Cutaneous. *Candidiasis, Oral. *Candidiasis, Vulvovaginal. *Mycoses. How long have you been taking it?. Choose one ...
Cutaneous candidiasis. *Lichen simplex chronicus. *Pemphigus vegetans. *Extramammary Paget syndrome. *Glucagonoma syndrome ...
9. [Extensive cutaneous candidiasis revealing cutaneous T-cell lymphoma: 2 cases].. Duong T; Ingen-Housz-Oro S; Gaulier A; ... 3. Primary cutaneous pleomorphic T-cell lymphoma expressing CD30 antigen.. Gianotti R; Alessi E; Cavicchini S; Berti E. Am J ... Primary Cutaneous T-cell Lymphoma With Aberrant CD-20 Expression.. Karimkhani C; McLaughlin C; Smith C. J Drugs Dermatol; 2015 ... Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.. Yoshizawa N; Yagi H; Horibe ...
Cutaneous candidiasis and thrush also occur. Invasive fungal infections also can occur. ...
Candidiasis [C01.150.703.160] * Candidiasis, Chronic Mucocutaneous [C01.150.703.160.088] * Candidiasis, Cutaneous [C01.150. ... use CANDIDIASIS, CUTANEOUS to search MONILIASIS, CUTANEOUS 1966-80. History Note. 81; was MONILIASIS, CUTANEOUS 1963-80. Date ... Candidiasis, Cutaneous Preferred Concept UI. M0003260. Scope Note. Candidiasis of the skin manifested as eczema-like lesions of ... Candidiasis, Cutaneous Preferred Term Term UI T006222. Date01/01/1999. LexicalTag NON. ThesaurusID NLM (1966). ...
Orally administered amphotericin B in the treatment of oral candidiasis in HIV-infected patients caused by azole-resistant ... Photodynamic therapy for the treatment of non-melanomatous cutaneous malignancies. Seminars in cutaneous medicine and surgery, ... Treatment of cutaneous leishmaniasis is directed toward the eradication of amastigotes and the reduction of the size of the ... Cutaneous leishmaniasis is an important health problem caused by the flagellated protozoa, Leishmania major and L. tropica. ...
The one patient with KS had cutaneous anergy and a decreased proportion of T-cells in his peripheral blood. The ratio of T- ... All nine patients with PCP also developed oral candidiasis. None of the patients was known to have an underlying illness ... Immunologic studies of the two survivors have shown cutaneous anergy, leukopenia, lymphopenia, and increased circulating immune ... anergic to multiple cutaneous recall antigens. An abnormally low ratio of T-helper to T-suppressor cells was present in six of ...
Cutaneous Candidiasis. *Mycotic Vulvovaginitis. *Mycotic balanitis. Read More. Concerns. Commonly asked questions. *. Onset of ...
Cutaneous C CN (8) Pharyngeal D CN (8) Ebola viral hemorrhagic fever C (9) DI Echinococcosis (hydatidosis) S Echovirus (see ... Candidiasis, all forms including mucocutaneous S Cat-scratch fever (benign inoculation lymphoreticulosis) S Cellulitis, ... cutaneous or pulmonary S Botulism S Bronchiolitis (see respiratory infections in infants and young children) Brucellosis ( ... cutaneous) Herpes simplex virus (neonatal or mucocutaneous) Impetigo Major (noncontained) abscesses, cellulitis, or decubiti ...
Candidiasis Cutánea/epidemiología; Adolescente; Adulto; Anciano; Candidiasis Cutánea/patología; Niño; Preescolar; Femenino; ... Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Candidiasis Cutánea Límite: Adolescente / ... Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: Candidiasis Cutánea Límite: Adolescente / ... Of these cases 174 (4.1%) were suspected as cutaneous candidosis. These cases belonged to 15 different nationalities. Both ...
What Is Cutaneous Candidiasis? Home Remedies For Cutaneous Candidiasis?. November 8, 2021 ...
Skin: Contusions, cutaneous hypersensitivity reactions, ecchymoses, pruritus. Rare cases of systemic eosinophilic conditions ( ... GI: Dental caries, tooth discoloration, esophageal candidiasis. Psychiatry: Agitation, aggression, anxiety, depression, ...
  • Cutaneous candidiasis and other forms of candidiasis are infections caused by the yeast Candida albicans or other Candida species. (medscape.com)
  • in the treatment of cutaneous candidiasis caused by Candida spp. (nih.gov)
  • Cutaneous candidiasis involves infection of the skin with candida . (diagnose-me.com)
  • When it affects the mouth and esophagus, candida overgrowth is known as oropharyngeal candidiasis or thrush. (journalofnaturalmedicine.com)
  • Candida can also infect the skin, this is known as cutaneous candidiasis. (journalofnaturalmedicine.com)
  • Cutaneous candidiasis caused by antifungal-resistant Candida sp. (edu.br)
  • Candida skin infections are known as cutaneous candidiasis. (intelligentlabs.org)
  • Oral candidiasis, also commonly referred to as oral thrush, can be described as a yeast infection caused by the genus Candida. (home-remedies-for-you.com)
  • Treatment of chronic mucocutaneous candidiasis has included drugs, immunotherapy, and replacement of nutritional and endocrine deficiency. (nih.gov)
  • This form of treatment offers advantages in safety and effectiveness over other therapies for chronic mucocutaneous candidiasis. (nih.gov)
  • Clotrimazole: intermittent therapy in chronic mucocutaneous candidiasis. (nih.gov)
  • Clotrimazole treatment of chronic mucocutaneous candidiasis. (nih.gov)
  • Newer investigational agents already in clinical trials include ibrexafungerp, a glucan-synthase inhibitor, that was approved in 2021 for the treatment of vulvo-vaginal candidiasis in oral formulation. (medscape.com)
  • Oropharyngeal candidiasis OPC can be treated with either topical antifungal agents (eg, nystatin, clotrimazole, amphotericin B oral suspension) or systemic oral azoles (fluconazole, itraconazole, or posaconazole). (medscape.com)
  • Antibiotics and oral contraceptives increase the risk of cutaneous candidiasis . (diagnose-me.com)
  • All nine patients with PCP also developed oral candidiasis. (cdc.gov)
  • In case you get infected with oral candidiasis, creamy white lesions will probably appear on your tongue and your inner cheeks. (home-remedies-for-you.com)
  • Oral candidiasis can affect people of all ages, but it is more common in those who wear dentures. (home-remedies-for-you.com)
  • In case you are suffering from diabetes or anemia, you are at a much higher risk of getting oral candidiasis. (home-remedies-for-you.com)
  • Therefore, getting adequate nutrition is a bit difficult for those who have oral candidiasis. (home-remedies-for-you.com)
  • In the initial stages, you may not recognize the symptoms for oral candidiasis, as they are fairly subtle. (home-remedies-for-you.com)
  • Yet, it is very common for the symptoms of oral candidiasis to last for a long period of time. (home-remedies-for-you.com)
  • The symptoms for oral candidiasis may be a bit different. (home-remedies-for-you.com)
  • It is absolutely essential to consult a doctor, as soon as any of the symptoms of oral candidiasis become evident. (home-remedies-for-you.com)
  • Also see the articles Mucosal Candidiasis and Candidiasis . (medscape.com)
  • There have been significant changes in the management of candidiasis in the last few years, particularly related to the appropriate use of echinocandins and expanded-spectrum azoles for candidemia, other forms of invasive candidiasis, and mucosal candidiasis. (medscape.com)
  • In women, a vaginal yeast infection is known as vulvovaginal candidiasis. (journalofnaturalmedicine.com)
  • Advancis Fungimax is a food supplement that helps in the treatment of various types of fungal infections, namely candidiasis (vaginal, skin, oropharyngeal), some types of onychomycosis, among others. (farmacianovadamaia.pt)
  • Vaginal candidiasis: take for 20 days (one box). (farmacianovadamaia.pt)
  • Cutaneous candidiasis is called Intertrigo when occurring under heavy skin folds. (diagnose-me.com)
  • This is called a vulvovaginal candidiasis (VVC) infection or "yeast infection. (medscape.com)
  • Yeast infections, also called candidiasis, are very common. (testing.com)
  • It's more commonly referred to as a yeast infection, with the medical term being candidiasis. (journalofnaturalmedicine.com)
  • What is Vulvovaginal Candidiasis? (medscape.com)
  • Cite this: Vulvovaginal Candidiasis - Medscape - Apr 29, 2010. (medscape.com)
  • Opportunistic pathogens infect immunocompromised hosts and include disseminated candidiasis and aspergillosis. (mhmedical.com)
  • Superficial infections of skin and mucous membranes are the most common types of cutaneous candidiasis. (medscape.com)
  • In cases of extensive cutaneous infections, infections in immunocompromised patients, folliculitis, or onychomycosis, systemic antifungal therapy is recommended. (medscape.com)
  • Cutaneous candidiasis - an evidence-based review of topical and systemic treatments to inform clinical practice. (nih.gov)
  • This child has a large rash caused by candidiasis, affecting the skin around the mouth. (medlineplus.gov)
  • Candidiasis of the skin is a fungal infection that causes a red, itchy rash. (healthline.com)
  • Learn about candidiasis of the skin causes, diagnosis, and treatment. (healthline.com)
  • Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (nih.gov)
  • Fungal infection as a cause of skin disease in the eastern province of Saudi Arabia: cutaneous candidosis. (bvsalud.org)
  • 9. [Extensive cutaneous candidiasis revealing cutaneous T-cell lymphoma: 2 cases]. (nih.gov)
  • Gagnez du temps : Sélectionnez en ligne, retirez en pharmacie buy antibiotics overnight . (reporda.com)
  • A revision of data outcomes on treatment of invasive candidiasis in clinical trials appears to favor use of echinocandins in terms of increased rate of survival. (medscape.com)
  • This type of finding may have an impact on future treatment recommendations and strategies of drug use for invasive candidiasis in different groups of patients. (medscape.com)
  • The parenteral formulation is still under investigation for the treatment of candidemia and invasive candidiasis. (medscape.com)
  • Of these cases 174 (4.1%) were suspected as cutaneous candidosis. (bvsalud.org)
  • Evidence of cellular immune dysfunction was present in the nine patients with PCP: eight were lymphopenic, and all nine were anergic to multiple cutaneous recall antigens. (cdc.gov)
  • 1. Gene expression profile in a case of primary cutaneous CD30-negative large T-cell lymphoma with a blastic phenotype. (nih.gov)
  • 7. [cFLIP diminishes CD95-induced apoptosis of CD30-stimulated cutaneous anaplastic large T cell lymphoma (cALCL) cells]. (nih.gov)
  • 8. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. (nih.gov)
  • 11. T cell receptor-gamma gene analysis of CD30+ large atypical individual cells in CD30+ large primary cutaneous T cell lymphomas. (nih.gov)
  • 18. Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma. (nih.gov)
  • 20. CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma. (nih.gov)
  • 16. Angioimmunoblastic lymphadenopathy-type peripheral T-cell lymphoma with cutaneous infiltration: report of a case and its gene expression profile. (nih.gov)
  • Immunologic studies of the two survivors have shown cutaneous anergy, leukopenia, lymphopenia, and increased circulating immune complexes. (cdc.gov)
  • Invasive fungal infections resulting from candidiasis are notable causes of illness and death in both adults and pediatric patients ( 1 - 4 ). (cdc.gov)
  • A STAT1-gain-of-function mutation causing Th17 deficiency with chronic mucocutaneous candidiasis, psoriasiform hyperkeratosis and dermatophytosis. (medscape.com)
  • Sarkadi AK, Taskó S, Csorba G, Tóth B, Erdős M, Maródi L. Autoantibodies to IL-17A may be correlated with the severity of mucocutaneous candidiasis in APECED patients. (medscape.com)
  • Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis. (medscape.com)
  • Of 38 heroin addicts treated for systemic candidal infections, 36 had metastatic cutaneous lesions (deep-seated scalp nodules and pustulosis in hairy zones), 15 had ocular localizations (mainly chorioretinitis), and 10 had osteoarticular involvement (vertebrae, costal cartilage, knees, and sacroiliac). (nih.gov)
  • Candidiasis of the skin manifested as eczema-like lesions of the interdigital spaces, perleche, or chronic paronychia. (nih.gov)
  • however, candidiasis accompanying IVDU became considerably rarer as the purity of the heroin supply increased. (cdc.gov)
  • Clinical features of Candidiasis in patients with inherited interleukin 12 receptor ß1 deficiency. (medscape.com)
  • Also see the articles Mucosal Candidiasis and Candidiasis . (medscape.com)